var data={"specialtyName":"Authors and Editors in Nephrology and Hypertension","contributorTypes":[{"name":"Editors-in-Chief","contributors":[{"name":"George L Bakris, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Hypertension\n","Professor of Medicine\n","The University of Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer; Boehringer Ingelheim; Relypsa; Vascular Dynamics [Diabetic neuropathy, diabetes, hypertension (Empagliflozin, patiromer)]. Consultant/Advisory Boards: AstraZeneca; Bayer; Boehringer Ingelheim; Relypsa; Vascular Dynamics; Merck [Nephropathy, diabetes, hypertension (Empagliflozin, Patiromer); Pfizer; NxStage [Diabetic neuropathy, diabetes, hypertension (Empagliflozin, patiromer)]."},{"name":"Jeffrey S Berns, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Dialysis\n","Professor of Medicine\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Amgen [Clinical Trial EC (Darbepoetin)]."},{"name":"Daniel C Brennan, MD, FACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Renal Transplantation\n","Professor of Medicine\n","Medical Director and Co-Director of the Comprehensive Transplant Center, Department of Internal Medicine, Division of Nephrology\n","Johns Hopkins Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion; CareDx; Oxford Immunotech; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, delayed graft function, immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, antithymocyte globulin)]. Speaker's Bureau: Alexion; Sanofi; Novartis; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, valganciclovir, antithymocyte globulin)]. Consultant/Advisory Boards: Alexion; Sanofi; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus, antithymocyte globulin)]."},{"name":"Michael Emmett, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Chief of Internal Medicine\n","Baylor University Medical Center"],"disclosure":"Consultant/Advisory Boards: ZS Pharma [Treatment of hyperkalemia (Potassium binder, zirconium silicate)]."},{"name":"Richard J Glassock, MD, MACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Glomerular Diseases\n","Emeritus Professor\n","The David Geffen School of Medicine at UCLA"],"disclosure":"Speaker's Bureau: Genentech [Vasculitis (Rituximab)]. Consultant/Advisory Boards: Bristol-Myers-Squibb [Lupus nephritis, FSGS (Abatacept)]; ChemoCentryx [Vasculitis, diabetes (Acocapan)]; Retrophin [FSGS(Sparsentan)]. Equity Ownership/Stock Options: Reata (Bardoxolone)."},{"name":"Stanley Goldfarb, MD","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Mineral and Bone Metabolism; Renal Ureteral Stones\n","Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Norman M Kaplan, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Hypertension\n","Clinical Professor of Internal Medicine\n","University of Texas Southwestern Medical Center"],"disclosure":""},{"name":"Steve J Schwab, MD","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Dialysis\n","Chancellor\n","University of Tennessee Health Science Center"],"disclosure":""},{"name":"Richard H Sterns, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Professor Emeritus\n","University of Rochester School of Medicine and Dentistry"],"disclosure":""}]},{"name":"Deputy Editors","contributors":[{"name":"John P Forman, MD, MSc","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Nephrology\n","Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Albert Q Lam, MD","credentials":["Deputy Editor — Nephrology\n","Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Alice M Sheridan, MD","credentials":["Deputy Editor — Nephrology\n","Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""}]},{"name":"Section Editors","contributors":[{"name":"Gerald B Appel, MD","credentials":["Section Editor — Glomerular Diseases\n","Professor of Medicine\n","Columbia University College of Physicians and Surgeons"],"disclosure":"Grant/Research/Clinical Trial Support: Regulus Therapeutics [Alport syndrome (RG-012, for injection)]; Bristol-Myers Squibb [Focal Segmental Glomerulosclerosis (Abatacept)]; Achillion [C3 Glomerulopathies (ACH-0144471, tablets)]; EMD Serono [Immunoglobulin A nephropathy (Atacicept)]; Reatta [Alport syndrome (Bardoxolone)]; Mallinkrodt [Focal Segmental Glomerulosclerosis (Corticotropin)]; Chemocentryx [C3 Glomerulopathies (Avacopan)]; Chemocentryx [Anti-Neutrophil Cytoplasmic Antibody Vasculitis (Avacopan)]. Speaker's Bureau: Genentech [Vasculitis (Rituximab)]; Sanofi [Side effects (Alemtuzumab)]. Consultant/Advisory Boards: Genentech; Takeda Pharmaceuticals; Bristol-Myers Squibb; Mallinckrodt Pharmaceuticals; EMD Serono; Merck; Pfizer; Genzyme-Sanofi; Omeros; Achillion Pharmaceuticals; Ionis; Reatta; Chemocentryx [Immunosuppressives (Drugs under development for immunosuppression)]."},{"name":"George L Bakris, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Hypertension\n","Professor of Medicine\n","The University of Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer; Boehringer Ingelheim; Relypsa; Vascular Dynamics [Diabetic neuropathy, diabetes, hypertension (Empagliflozin, patiromer)]. Consultant/Advisory Boards: AstraZeneca; Bayer; Boehringer Ingelheim; Relypsa; Vascular Dynamics; Merck [Nephropathy, diabetes, hypertension (Empagliflozin, Patiromer); Pfizer; NxStage [Diabetic neuropathy, diabetes, hypertension (Empagliflozin, patiromer)]."},{"name":"Jeffrey S Berns, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Dialysis\n","Professor of Medicine\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Amgen [Clinical Trial EC (Darbepoetin)]."},{"name":"Daniel C Brennan, MD, FACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Renal Transplantation\n","Professor of Medicine\n","Medical Director and Co-Director of the Comprehensive Transplant Center, Department of Internal Medicine, Division of Nephrology\n","Johns Hopkins Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion; CareDx; Oxford Immunotech; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, delayed graft function, immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, antithymocyte globulin)]. Speaker's Bureau: Alexion; Sanofi; Novartis; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, valganciclovir, antithymocyte globulin)]. Consultant/Advisory Boards: Alexion; Sanofi; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus, antithymocyte globulin)]."},{"name":"John M Burkart, MD","credentials":["Section Editor — Dialysis\n","Professor of Medicine/Nephrology\n","Wake Forest University Medical Center"],"disclosure":"Employment: Health Systems Management."},{"name":"Gary C Curhan, MD, ScD","credentials":["Section Editor — Chronic Kidney Disease\n","Editor-in-Chief Emeritus\n","Clinical Journal of the American Society of Nephrology\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Allena Pharmaceuticals [Oxalate]. Consultant/Advisory Boards: Allena Pharmaceuticals [Oxalate, nephrolithiasis]; Decibel Therapeutics (Hearing loss/tinnitus); Shire [hypoparathyroidism]; RenalGuard [Acute kidney injury]. Consultant/Advisory Boards (spouse/partner): Decibel Therapeutics (Hearing loss, tinnitus)]. Equity Ownership/Stock Options: Allena Pharmaceuticals. Other Financial Interest: American Society of Nephrology [CJASN Editor-in-Chief]."},{"name":"Michael Emmett, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Chief of Internal Medicine\n","Baylor University Medical Center"],"disclosure":"Consultant/Advisory Boards: ZS Pharma [Treatment of hyperkalemia (Potassium binder, zirconium silicate)]."},{"name":"Fernando C Fervenza, MD, PhD","credentials":["Section Editor — Glomerular Diseases \n","Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial support: Genentech [Membranous nephropathy, Fibrillary GN (Rituximab)]; Mallinckrodt [IgA nephropathy] and FSGS(Corticotropin injection gel)]; Janssen Pharmaceutical [Monoclonal protein-mediated renal diseases (Daratumumab)]. Consultant/Advisory Boards: Alexion pharmaceutical [complement-mediated diseases]; Visterra pharmaceutical [complement-mediated diseases]. Employment: Mayo Clinic."},{"name":"Richard J Glassock, MD, MACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Glomerular Diseases\n","Emeritus Professor\n","The David Geffen School of Medicine at UCLA"],"disclosure":"Speaker's Bureau: Genentech [Vasculitis (Rituximab)]. Consultant/Advisory Boards: Bristol-Myers-Squibb [Lupus nephritis, FSGS (Abatacept)]; ChemoCentryx [Vasculitis, diabetes (Acocapan)]; Retrophin [FSGS(Sparsentan)]. Equity Ownership/Stock Options: Reata (Bardoxolone)."},{"name":"Stanley Goldfarb, MD","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Mineral and Bone Metabolism; Renal Ureteral Stones\n","Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Thomas A Golper, MD","credentials":["Section Editor — Dialysis\n","Professor of Medicine\n","Vanderbilt University Medical Center"],"disclosure":"Consultant/Advisory Board: Keryx [Peritoneal dialysis (Ferric citrate)]."},{"name":"Lee A Hebert, MD","credentials":["Section Editor — Glomerular Diseases \n","Professor of Medicine\n","Ohio State University \n","Wexner College of Medicine and Public Health"],"disclosure":"Consultant/Advisory Boards: Best Doctors in America [Glomerular diseases]; ARDEA [Uricosuric drug]; Alexion [Eculizumab]."},{"name":"Norman M Kaplan, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Hypertension\n","Clinical Professor of Internal Medicine\n","University of Texas Southwestern Medical Center"],"disclosure":""},{"name":"Jonathan B Kruskal, MD, PhD","credentials":["Section Editor — Kidney Disease\n","Professor of Radiology\n","Harvard Medical School"],"disclosure":""},{"name":"Christophe Legendre, MD","credentials":["Section Editor — Renal Transplantation\n","Professor of Nephrology\n","Université Paris Descartes\n","Head of the Adult Nephrology and Transplantation Unit\n","Hôpital Necker"],"disclosure":"Speaker's Bureau: Alexion, Novartis [Transplantation (Everolimus, Eculizumab). Consultant/Advisory Boards: Alexion [Transplantation (Eculizumab)]."},{"name":"Barbara Murphy, MB, BAO, BCh, FRCPI","credentials":["Section Editor — Renal Transplantation\n","Professor of Medicine\n","Mount Sinai School of Medicine"],"disclosure":"Consultant/Advisory Boards: Novartis [Transplant DSMB (Anti-CD40)]; Hensa Pharmaceutical [DSMB]."},{"name":"Paul M Palevsky, MD","credentials":["Section Editor — Renal Failure\n","Professor of Medicine\n","University of Pittsburgh\n","VA Pittsburgh Healthcare System"],"disclosure":"Grant/Research/Clinical Trial Support: Spectral Medical [Sepsis (Endotoxin assay)]. Consultant/Advisory Boards: Baxter [Dialysis (Hemodialysis equipment, peritoneal dialysis equipment and supplies, continuous renal replacement therapy equipment and solutions)]; Durect [Potential agent for AKI]; HealthSpan Dx [Novel diagnostic test for prediction of AKI]; GE Healthcare [Radiocontrast agents and equipment]."},{"name":"Ronald D Perrone, MD","credentials":["Section Editor — Cystic Disease\n","Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [Polycystic kidney disease (Tolvaptan)]; Kadmon [Polycystic kidney disease (Tesevatinib)]; Department of Defense [Polycystic kidney disease (Metformin)]. Consultant/Advisory Boards: Otsuka [Polycystic kidney disease (Tolvaptan)]; Novartis [Polycystic kidney disease]; Misubishi Tanabe [Polycystic kidney disease]; Sanofi-Genzyme [Polycystic kidney disease]."},{"name":"Glenn M Preminger, MD","credentials":["Section Editor — Renal Ureteral Stones\n","Professor of Urologic Surgery\n","Duke University Medical Center\n","Director of Education\n","Endourological Society"],"disclosure":"Consultant/Advisory Boards: Retrophin [Cystine stones (Tiopronin)]; Boston Scientific [Surgical stone management (Endourology equipment)]."},{"name":"L Darryl Quarles, MD","credentials":["Section Editor — Renal Osteodystrophy\n","Director, Division of Nephrology\n","Associate Dean for Research\n","The University of Tennessee Health Science Center"],"disclosure":"Speaker's Bureau: Amgen [Calcimimetic (Cinacalcet)]."},{"name":"Brad H Rovin, MD","credentials":["Section Editor — Glomerular Diseases \n","Professor of Medicine and Pathology\n","The Ohio State University College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Glomerular Diseases/Molecular Interrogation of Kidney Biopsies, Precision Medicine/Biomarkers]. Consultant/Advisory Boards: Alexion [Lupus Nephritis (Eucluzimab)]; Aurinia [Lupus Nephritis, FSGS (Voclosporin)]; Biogen Idec [Lupus Nephritis (Anti-TWEAK)];  Biomarin [Hereditary Disorders of Metabolic Disorders (Pegvaliase)]; Bristol Myers Squibb [FSGS, MCD (Abatacept)]; Chemocentryx [Lupus Nephritis, ANCA Vasculitis, C3 Glomerulopathy (Avacopan)]; EMD Serono [IgA Nephropathy (Atacicept)]; Frazier Life Sciences [Lupus Nephritis]; Genentech [Lupus Nephritis, ANCA Vasculitis (Rituximab, Obinutuzumab)]; Lupus Foundation of America [Lupus Nephritis]; Mallinkrodt [Lupus Nephritis, FSGS (ACTHAR Gel)]; Medimmune [Lupus Nephritis (Anti-interferon)]; Novartis [IgA Nephropathy (Factor B Inhibitor)]; Pharmalink [IgA Nephropathy]; Retrophin [IgA Nephropathy (Sparsenten)]; Rigel [IgA Nephropathy (Fostamatinib])."},{"name":"Steve J Schwab, MD","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Dialysis\n","Chancellor\n","University of Tennessee Health Science Center"],"disclosure":""},{"name":"Richard H Sterns, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Professor Emeritus\n","University of Rochester School of Medicine and Dentistry"],"disclosure":""},{"name":"William B White, MD","credentials":["Section Editor — Hypertension\n","Professor of Medicine\n","Chief, Hypertension and Clinical Pharmacology\n","Calhoun Cardiology Center \n","University of Connecticut School of Medicine, Farmington\n","Past President\n","American Society of Hypertension 2012-2014\n","Editor-in-Chief\n","Blood Pressure Monitoring"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Vascular medicine]. Consultant/Advisory Boards: Data Safety Monitoring Boards: Teva [Multiple sclerosis (Laquinimod)]; Lundbeck [Hypotension (Droxidopa)]; Steering Committees: Takeda [Diabetes (Alogliptin)], Relypsa [Hyperkalemia (Patiromer)]; Cardiovascular End Point Committees: Takeda [Gout (Febuxostat)]; Forest [COPD (Roflumilast and Aclidinium)]; Roche [Anemia (Mircera)]; AstraZeneca [COPD]."}]},{"name":"Editorial Assistants","contributors":[{"name":"Megan McLaurin, BA, BS","credentials":["Editorial Assistant ─ UpToDate"],"disclosure":""},{"name":"Rebecca Mueller, BA","credentials":["Senior Editorial Assistant — UpToDate"],"disclosure":""},{"name":"Elizabeth Packer, MA","credentials":["Development Editor — UpToDate"],"disclosure":""}]},{"name":"Authors","contributors":[{"name":"Behdad Afzali, MRCP, PhD, PGDip, FHEA, MAcadMEd","credentials":["Wellcome Trust Intermediate Research Fellow\n","King's College Honorary Consultant Nephrologist\n","Guy's and St Thomas's Hospitals, NHS Trust, UK\n","Guest Researcher, National Institutes of Health, USA"],"disclosure":""},{"name":"Rajiv Agarwal, MD","credentials":["Professor of Medicine\n","Indiana University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Janssen; Bayer [Blood pressure (Blood pressure medications)]."},{"name":"Nada Alachkar, MD","credentials":["Associate Professor of Medicine, Division of Nephrology\n","The Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Muhammad Alam, MD, MPH","credentials":["Staff Nephrologist\n","Kidney Care Center, Little Rock, AR"],"disclosure":""},{"name":"Barbara D Alexander, MD, MHS","credentials":["Professor of Medicine and Pathology \n","Duke University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [Fungal disease (Isavuaconazole, micafungin, liposomal amphotericin B)]; Synexis [Fungal disease (New antifungal agent)]; Viamet [Fungal disease (New antifungal agent)]; Gilead [Respiratory syncytial virus]; Shire [Cytomegalovirus infection (Mirabivir)]. Consultant/Advisory Boards: Shire [Cytomegalovirus infection (Mirabivir)]; Astellas [Fungal infections (Isavuconazole)]; Cidara [Fungal infections (New antifungal agent)]; Scynexis [Fungal disease (New antifungal agent)]; Lediant [Fungal disease (Amphotericin B lipid complex)]."},{"name":"Tarek Alhamad, MD, MS, FACP, FASN","credentials":["Assistant Professor of Medicine\n","Washington University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Mallinckrodt [Nephrotic syndrome (ACTH gel)]; Angion [BB3 analogue]. Speaker's Bureau: Veloxis [Immunosuppression medications (Tacrolimus XR)]. Consultant/Advisory Board: Veloxis [Immunosuppression medications (Tacrolimus XR)]."},{"name":"Michael Allon, MD","credentials":["Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":"Consultant/Advisory Boards: Cormedix [Dialysis catheter infections (nonantibiotic antimicrobial solution)]."},{"name":"Rita R Alloway, PharmD, BCPS","credentials":["Research Professor of Medicine\n","Director, Transplant Clinical Research\n","Director, Transplant Specialty Residency and Fellowship\n","University of Cincinnati"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [Renal transplantation (Tacrolimus)]; Veloxis [Renal transplantation (Tacrolimus)]; Bristol Myers Squibb [Renal transplantation (Belatacept)]; Novartis [Renal transplantation (Anti-CD40 ligand)]; FDA [Renal transplantation (Generic tacrolimus products)]. Speaker's Bureau: Genzyme [Renal transplantation (Antithymocyte globulin)]; Veloxis [Renal transplantation (Tacrolimus extended-release tablets)]. Consultant/Advisory Boards: Genzyme [Renal transplantation (Antithymocyte globulin)]."},{"name":"Richard F Ambinder, MD, PhD","credentials":["James B Murphy Professor of Oncology\n","Johns Hopkins School of Medicine"],"disclosure":"Consultant/Advisory Boards: Bristol-Myers Squibb [Cancer drugs (Checkpoint inhibitors)]; Viracta [Cancer drugs (Therapeutic trial for unlicensed drug)]; Cellgenesis [Cancer drugs (Imides, proteasome inhibitors)]; National Comprehensive Cancer Network [Hodgkin lymphoma, HIV malignancy)]."},{"name":"Connie Anderson, BSN, RN, MBA","credentials":["Vice President of Clinical Operation Northwest Kidney Centers\n","University of Washington School of Nursing, Dean’s Advisory Committee"],"disclosure":""},{"name":"Dany Anglicheau, MD, PhD","credentials":["Professor of Nephrology, Department of Nephrology and Kidney Transplantation\n","Necker Hospital, APHP & Paris Descartes University"],"disclosure":""},{"name":"Gerald B Appel, MD","credentials":["Section Editor — Glomerular Diseases\n","Professor of Medicine\n","Columbia University College of Physicians and Surgeons"],"disclosure":"Grant/Research/Clinical Trial Support: Regulus Therapeutics [Alport syndrome (RG-012, for injection)]; Bristol-Myers Squibb [Focal Segmental Glomerulosclerosis (Abatacept)]; Achillion [C3 Glomerulopathies (ACH-0144471, tablets)]; EMD Serono [Immunoglobulin A nephropathy (Atacicept)]; Reatta [Alport syndrome (Bardoxolone)]; Mallinkrodt [Focal Segmental Glomerulosclerosis (Corticotropin)]; Chemocentryx [C3 Glomerulopathies (Avacopan)]; Chemocentryx [Anti-Neutrophil Cytoplasmic Antibody Vasculitis (Avacopan)]. Speaker's Bureau: Genentech [Vasculitis (Rituximab)]; Sanofi [Side effects (Alemtuzumab)]. Consultant/Advisory Boards: Genentech; Takeda Pharmaceuticals; Bristol-Myers Squibb; Mallinckrodt Pharmaceuticals; EMD Serono; Merck; Pfizer; Genzyme-Sanofi; Omeros; Achillion Pharmaceuticals; Ionis; Reatta; Chemocentryx [Immunosuppressives (Drugs under development for immunosuppression)]."},{"name":"Lawrence J Appel, MD, MPH","credentials":["C. David Molina Professor of Medicine \n","Johns Hopkins University School of Medicine"],"disclosure":"Other Financial Interest:Johns Hopkins has an institutional conflicting of interest, as described below. “Healthways, Inc. developed the website for both interventions used in the POWER trial in collaboration with Johns Hopkins investigators and provided coaching effort for the transtelephonic intervention. Healthways also provided some research funding to supplement NIH support. Under an institutional consulting agreement with Healthways, the Johns Hopkins University received fees for advisory services to Healthways during the POWER trial. Faculty members who participated in the consulting services received a portion of the University fees. On the basis of POWER trial results, Healthways developed and is commercializing a weight-loss intervention program called Innergy. Under an agreement with Healthways, Johns Hopkins faculty monitor the Innergy program’s content and process (staffing, training, and counseling) and outcomes (engagement and weight loss ) to ensure consistency with the corresponding arm of the POWER Trial. Johns Hopkins receives fees for these services and faculty members who participate in the consulting services receive a portion of these fees. Johns Hopkins receives royalty on sales of the Innergy program.”"},{"name":"Andrew Arnold, MD","credentials":["Murray-Heilig Professor of Molecular Medicine\n","University of Connecticut"],"disclosure":""},{"name":"Robert M Arnold, MD","credentials":["Editor-in-Chief — Palliative Care\n","Section Editor — General Principles of Palliative Care\n","Chief, Section of Palliative Care and Medical Ethics\n","University of Pittsburgh School of Medicine"],"disclosure":""},{"name":"Mark D Aronson, MD","credentials":["Editor-in-Chief — Primary Care (Adult); Hospital Medicine\n","Section Editor — General Medicine\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Akhtar Ashfaq, MD","credentials":["Assistant Professor of Medicine\n","Albert Einstein College of Medicine"],"disclosure":""},{"name":"Jon C Aster, MD","credentials":["Professor of Pathology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Regeneron [Hematologic malignancies (Notch inhibitors)]; Lilly [Hematologic malignancies (Notch inhibitors)]; Cellestia [Hematologic malignancies (Notch inhibitors)]; Anastasis [Hematologic malignancies (Notch inhibitors)]. Equity Ownership/Stock Options: Cellestia; Anastasis."},{"name":"Phyllis August, MD, MPH","credentials":["Ralph A Baer, MD Professor of Research in Medicine\n","Director, Hypertension Center\n","Division of Nephrology & Hypertension\n","Weill Cornell Medical College"],"disclosure":""},{"name":"Seema Baid-Agrawal, MD","credentials":["Associate Professor of Medicine\n","Sahlgrenska Medical University, Gothenburg, Sweden"],"disclosure":""},{"name":"George L Bakris, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Hypertension\n","Professor of Medicine\n","The University of Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer; Boehringer Ingelheim; Relypsa; Vascular Dynamics [Diabetic neuropathy, diabetes, hypertension (Empagliflozin, patiromer)]. Consultant/Advisory Boards: AstraZeneca; Bayer; Boehringer Ingelheim; Relypsa; Vascular Dynamics; Merck [Nephropathy, diabetes, hypertension (Empagliflozin, Patiromer); Pfizer; NxStage [Diabetic neuropathy, diabetes, hypertension (Empagliflozin, patiromer)]."},{"name":"Douglas W Ball, MD","credentials":["Associate Professor of Medicine and Oncology\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Rasheed A Balogun, MD","credentials":["Professor of Medicine\n","University of Virginia"],"disclosure":""},{"name":"Steven J Bander, MD","credentials":["Associate Professor of Medicine\n","St. Louis University\n","Medical Director, Vascular Access Center\n","St. Luke's Hospital"],"disclosure":""},{"name":"Shweta Bansal, MD, FASN","credentials":["Associate Professor of Medicine\n","Division of Nephrology, UT Health Science Center at San Antonio"],"disclosure":""},{"name":"Jonathan Barratt, PhD, FRCP","credentials":["Professor; Honorary Consultant Nephrologist\n","University of Leicester, UK"],"disclosure":"Consultant/Advisory Boards: Omeros [IgA nephropathy (OMS721)]; Anthera [IgAN (Blisibimob)]; EMD Serono [IgAN (Atacicept)]; Pharmalink [IgAN (Nefecon)]; Rigel [IgAN (Fostamatnib)]."},{"name":"Rashad S Barsoum, MD, FRCP, FRCPE","credentials":["Emeritus Professor of Medicine\n","Kasr El-Aini Medical School, Cairo University, Egypt"],"disclosure":""},{"name":"Jan Basile, MD","credentials":["Professor of Medicine\n","Medical University of South Carolina\n","Ralph H Johnson Veterans Affairs Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: NHLBI [Hypertension]. Speaker's Bureau: Arbor Pharmaceuticals [Hypertension (Azilsartan)]; Janssen [Diabetes (Canagliflozin)]. Consultant/Advisory Boards: Actavis [Hypertension (Nebivolol)]; Amgen [Lipid-lowering (Evolocumab)]; Arbor Pharmaceuticals [Hypertension (Azilsartan)]; Lilly [Diabetes (Dulaglutide)]; Janssen [Diabetes (Canagliflozin)]."},{"name":"John F Beary, III, MD","credentials":["Clinical Professor of Medicine\n","University of Cincinnati"],"disclosure":""},{"name":"Gerald A Beathard, MD, PhD","credentials":["Clinical Professor\n","University of Texas Medical Branch"],"disclosure":"Employment: DaVita [Dialysis provider]- No relevant conflict on topic."},{"name":"Gillian Beauchamp, MD","credentials":["Assistant Professor\n","University of South Florida Morsani College of Medicine\n","Lehigh Valley Health Network Department of Emergency and Hospital Medicine"],"disclosure":""},{"name":"Laurence H Beck, Jr, MD, PhD","credentials":["Associate Professor of Medicine\n","Boston University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Clinical and experimental membranous nephropathy]. Patent Holder: Boston University Medical Center [Membranous nephropathy (Diagnostics in membranous nephropathy)]."},{"name":"Carolyn B Becker, MD","credentials":["Associate Professor of Medicine\n","Brigham and Women's Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"Michael A Becker, MD","credentials":["Section Editor — Crystal Diseases\n","Professor Emeritus of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda [Urate-lowering drug safety/efficacy in gout (Febuxostat, colchicine)]; Horizon [Urate-lowering drug safety/efficacy in gout (Pegloticase)]; Ardea Biosciences/AstraZeneca and Ironwood [Urate-lowering drug safety/efficacy in gout (Lesinurad)]. Consultant/Advisory Boards: Takeda Pharmaceuticals [Gout drug development (Febuxostat, colchicine)]; Horizon [Gout drug development (Pegloticase)]; Ardea Biosciences/AstraZeneca and Ironwood [Gout drug development (Lesinurad)]; CymaBay Therapeutics, Kowa Pharmaceuticals [Gout drug development (Arhalofenate)]."},{"name":"Srinivasan Beddhu, MD","credentials":["Professor of Medicine\n","University of Utah School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Diabetic kidney disease (Atrasentan)]; Bayer [Diabetic kidney disease (Fineronone)]. Consultant/Advisory Boards: Reata [Diabetic kidney disease]."},{"name":"Alessandro Bellucci, MD","credentials":["Associate Professor of Medicine\n","Hofstra-North Shore LIJ School of Medicine"],"disclosure":""},{"name":"Costantino Benedetti, MD","credentials":["Professor of Clinical Anesthesiology\n","Ohio State University"],"disclosure":""},{"name":"William M Bennett, MD","credentials":["Medical Director\n","Legacy Good Samaritan Transplant Services"],"disclosure":""},{"name":"James R Berenson, MD","credentials":["Medical and Scientific Director\n","Institute for Myeloma and Bone Cancer Research"],"disclosure":""},{"name":"Michael Berkoben, MD","credentials":["Associate Professor of Medicine\n","Duke University Medical Center"],"disclosure":""},{"name":"Bonnie L Bermas, MD","credentials":["Professor of Medicine\n","UT Southwestern Medical Center"],"disclosure":""},{"name":"Jeffrey S Berns, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Dialysis\n","Professor of Medicine\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Amgen [Clinical Trial EC (Darbepoetin)]."},{"name":"Daniel G Bichet, MD","credentials":["Professor of Medicine\n","Universite de Montreal"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry (Migalastat)], Shire [Fabry (Replagal)], Sanofi Genzyme [Fabry (Fabrazyme)]. Speaker's Bureau: Otsuka Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry (Migalastat)], Sanofi Genzyme [Fabry (Fabrazyme)]. Consultant/Advisory Boards: Otsuka Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry (Migalastat)], Sanofi Genzyme [Fabry (Fabrazyme)]."},{"name":"John D Bisognano, MD, PhD","credentials":["Professor of Medicine, Cardiology\n","University of Rochester Medical Center"],"disclosure":""},{"name":"Robert M Black, MD","credentials":["Professor of Clinical Medicine\n","University of Massachusetts Medical Center"],"disclosure":""},{"name":"James H Black, III, MD","credentials":["Associate Professor of Surgery\n","Johns Hopkins University"],"disclosure":""},{"name":"Christopher R Blagg, MD, FRCP","credentials":["Professor Emeritus of Medicine\n","University of Washington"],"disclosure":""},{"name":"Peter J Blankestijn, MD","credentials":["Associate Professor in Nephrology\n","University Medical Center, Utrecht, The Netherlands"],"disclosure":""},{"name":"Anthony Bleyer, MD, MS","credentials":["Professor of Internal Medicine/Nephrology\n","Wake Forest University School of Medicine"],"disclosure":""},{"name":"Michael J Bloch, MD, FACP, FASH, FSVM, FNLA","credentials":["Associate Professor, University of Nevada School of Medicine\n","Medical Director, Vascular Care, Renown Regional Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Diabetes (Dapagliflozin)]; Recor [Hypertension (renal denervation catheter)]. Speaker's Bureau: Jansen [Anticoagulation (Rivaroxaban)]; Amgen [Lipids (Evolucumab)]. Consultant/Advisory Boards: Amgen [Lipids (Evolucumab)]; Takeda [Hypertension (Azilsartan)]."},{"name":"Roy D Bloom, MD","credentials":["Professor of Medicine\n","University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Veloxis Pharmaceuticals [Immunosuppression (Tacrolimus)]; Care DX [Diagnostics (DNA blood test)]. Consultant/Advisory Boards: Abbvie [Hepatitis C (Ombitasvir, paritaprevir, ritonavir, plus dasabuvir)]; Merck [Hepatitis C (Elbasvir and grazoprevir)]; Care Dx [Diagnostics (DNA blood test)]."},{"name":"Gerald S Bloomfield, MD, MPH","credentials":["Assistant Professor of Medicine & Global Health\n","Duke University"],"disclosure":""},{"name":"John B Bodensteiner, MD","credentials":["Senior Associate Consultant in Child and Adolescent Neurology\n","Mayo Clinic College of Medicine"],"disclosure":"Consultant/Advisory Boards: Ionis (Isis) Pharmaceuticals [SMA DSMB]; American Board of Psychiatry and Neurology [Director]."},{"name":"Michael Bodmer, MD, MSc","credentials":["Head\n","Medical Department\n","Zuger Kantonsspital\n","Baar, Switzerland"],"disclosure":""},{"name":"Andrew S Bomback, MD, MPH","credentials":["Assistant Professor of Medicine\n","Columbia University Medical Center"],"disclosure":""},{"name":"Barry A Borlaug, MD","credentials":["Section Editor — Heart Failure\n","Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca; Corvia; MAST Therapeutics; Medtronic; Mesoblast; GlaxoSmithKline; Novartis [Heart failure]. Consultant/Advisory Boards: Actelion; Amgen; Merck; AstraZeneca; MyoKardia [Heart failure]."},{"name":"Roger Bouillon, MD, PhD, FRCP","credentials":["Professor of Medicine\n","Katholieke Universiteit Leuven, Belgium"],"disclosure":"Speaker's Bureau: Amgen; Chugai Pharmaceutical; Teijin; Abiogen Pharma [Vitamin D (Vitamin D, Vitamin D analogs/metabolites)]. Patent Holder: Hybrigenics [Vitamin D analogs (Inecalcitol)]."},{"name":"Edward W Boyer, MD, PhD","credentials":["Director of Academic Development \n","Department of Emergency Medicine \n","Brigham and Women's Hospital\n","Associate Professor of Emergency Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: NIDA [Drug abuse]. Other Financial Interest: DePuy [Cobalt toxicity]."},{"name":"D Craig Brater, MD","credentials":["Emeritus Dean, Indiana University School of Medicine\n","Vice President for Programs, Regenstrief Foundation"],"disclosure":""},{"name":"Daniel C Brennan, MD, FACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Renal Transplantation\n","Professor of Medicine\n","Medical Director and Co-Director of the Comprehensive Transplant Center, Department of Internal Medicine, Division of Nephrology\n","Johns Hopkins Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion; CareDx; Oxford Immunotech; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, delayed graft function, immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, antithymocyte globulin)]. Speaker's Bureau: Alexion; Sanofi; Novartis; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate, valganciclovir, antithymocyte globulin)]. Consultant/Advisory Boards: Alexion; Sanofi; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection, long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus, antithymocyte globulin)]."},{"name":"Sergey V Brodsky, MD, PhD","credentials":["Associate Professor\n","Department of Pathology, The Ohio State University"],"disclosure":""},{"name":"Edward M Brown, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Patent Holder/Royalties: NPS Pharmaceuticals [Hyperparathyroidism (Cinacalcet)]."},{"name":"Nicholas A Buckley, MD, FRACP","credentials":["Professor of Clinical Pharmacology\n","University of Sydney Medical School\n","Clinical Toxicologist\n","Royal Prince Alfred Hospital"],"disclosure":""},{"name":"John M Burkart, MD","credentials":["Section Editor — Dialysis\n","Professor of Medicine/Nephrology\n","Wake Forest University Medical Center"],"disclosure":"Employment: Health Systems Management."},{"name":"David L Burns, MD","credentials":["Associate Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Michael J Burns, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"David A Calhoun, MD","credentials":["Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: ReCore [Resistant Hypertension (Renal Nerve Denervation device)]; Medtronic [Clinical studies of resistant hypertension (Renal Nerve Denervation device)]. Consultant/Advisory Boards: Novartis [Resistant hypertension]; Mitsubishi Tanabe [Resistant hypertension]."},{"name":"Daniel C Cattran, MD","credentials":["Professor of Medicine\n","University of Toronto, Canada"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Membranous nephropathy, FSGS (Rituximab)]; Chemocentryx [FSGS]. Consultant/Advisory Boards: Mallinckrodt [Membranous nephropathy; focal and segmental glomerulosclerosis (ACTH long-acting gel)]; Omerus [IgA]; Chemocentryx [Vasculitis (C3G), FSGS]."},{"name":"Alessandro Ceschi, MD, FEAPCCT","credentials":["Medical and Scientific Director\n","Institute of Pharmacological Sciences of Southern Switzerland\n","Division Head of Clinical Pharmacology and Toxicology\n","Ente Ospedaliero Cantonale, Lugano, Switzerland\n","Consultant of Clinical Pharmacology and Toxicology\n","University Hospital Zurich, Switzerland"],"disclosure":""},{"name":"Tak-Mao Chan, MD, FRCP","credentials":["Chair Professor & Yu Chiu Kwong Endowed Professor in Medicine\n","University of Hong Kong"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [nephrology/rheumatology/lupus nephritis (tacrolimus)]. Consultant/Advisory Boards: Astellas [nephrology/rheumatology/lupus nephritis (tacrolimus)]; AstraZeneca [nephology/rheumatology/lupus nephritis (a biologic in Phase 2 program)]; Novartis [nephology/rheumatology/lupus nephritis (a biologic in Phase 2/3 program]."},{"name":"Anil Chandraker, MD, FASN, FRCP","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [Antibody-mediated rejection (Eculizumab)]. Consultant/Advisory Boards: T2 Biosystems; Dompé; Veloxis [Immunosuppression (Tacrolimus)]."},{"name":"Arlene B Chapman, MD","credentials":["Professor of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":""},{"name":"Julia F Charles, MD, PhD","credentials":["Associate Physician\n","Brigham and Women's Hospital\n","Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards (Spouse): Veracyte. Equity Ownership/Stock Options (Spouse): Metera Pharmaceuticals; Numera Biosciences."},{"name":"Horng H Chen, MD","credentials":["Professor of Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"Alfred K Cheung, MD","credentials":["Professor of Internal Medicine\n","University of Utah School of Medicine"],"disclosure":"Consultant/Advisory Boards: Baxter [DSMB for dialysis trial (Dialysis machines and supplies)]; Boehringer Ingelheim [DSMB (Empagliflozin)]. Equity Ownership/Stock Options: Merck."},{"name":"Chee Kay Cheung, PhD, MRCP","credentials":["Clinical Lecturer\n","University of Leicester, UK"],"disclosure":""},{"name":"Arkadi A Chines, MD","credentials":["Clinical Professor of Medicine\n","University of California, Los Angeles"],"disclosure":""},{"name":"Monique E Cho, MD","credentials":["Division of Nephrology and Hypertension\n","University of Utah School of Medicine"],"disclosure":""},{"name":"W James Chon, MD, FACP, FASN, FAST","credentials":["Associate Professor\n","University of Missouri-Kansas City (UMKC) School of Medicine\n","Medical Director, Renal Transplant Program\n","St. Luke's Health System"],"disclosure":""},{"name":"Tushar A Chopra, MD","credentials":["Assistant Professor Of Medicine\n","University of Virginia Health System"],"disclosure":""},{"name":"Gabriel Choukroun, MD, PhD","credentials":["Head of Nephrology, Dialysis, Transplantation Department\n","CHU Amiens and Picardie University"],"disclosure":"Consultant/Advisory Boards: VIFOR [Iron therapy (Ferrinject) and Hyperphosphatemia (Velforo)]; AMGEN [Hyperparathyroidism (Etelcalcetide)]"},{"name":"Megan B Clowse, MD, MPH","credentials":["Assistant Professor of Medicine\n","Duke University Medical Center\n","Division of Rheumatology and Immunology"],"disclosure":""},{"name":"Adi Cohen, MD, MHS","credentials":["Associate Professor of Medicine\n","Columbia University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Osteoporosis (Denosumab)]; Eli Lilly [Osteoporosis (Teriparatide)]. Consultant/Advisory Boards (Spouse): Annapurna Pharmaceuticals [Cardiology (No relevant product)]."},{"name":"Wilson S Colucci, MD","credentials":["Section Editor — Heart Failure\n","Professor of Medicine\n","Boston University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Novartis [Heart failure (Valsartan, sacubitril/valsartan)], Merck [Heart failure (Enalapril)], Amgen [Heart failure (Ivabradine)]."},{"name":"Michael J Connor, Jr, MD","credentials":["Assistant Professor - Critical Care Medicine & Nephrology\n","Emory University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Baxter [CRRT (On site PI)."},{"name":"Robin Conwit, MD","credentials":["Program Director, Division of Extramural Research\n","National Institutes of Health, National Institute of Neurological Disorders and Stroke"],"disclosure":""},{"name":"Mary Corretti, MD, FACC","credentials":["Associate Professor of Medicine\n","Johns Hopkins Hospital School of Medicine"],"disclosure":""},{"name":"Steven Coutre, MD","credentials":["Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Gary M Cox, MD","credentials":["Professor of Medicine\n","Duke University Medical Center"],"disclosure":""},{"name":"Daniel W Coyne, MD","credentials":["Professor of Medicine\n","Washington University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen [Diabetes (Canigloflozin)]; Fibrogen [Anemia (Investigational)]; GSK [Anemia (Investigational)]; ZS Pharma [Hyperkalemia (Investigational)]; Clegene [Anemia (Investigational)]; Eli Lily [Anemia (Investigational)]; Medibeacon [GFR measurement (Investigational)]. Speaker's Bureau: Fresenius Medical Care Group [Phosphate binder (Sucroferric oxyhydroxide)]. Consultant/Advisory Boards: Fresenius [Phosphate binder (Sucroferric oxyhydroxide)]; Vifor [IV irons (Ferric carboxymaltose)]; Eli Lilly [Anemia (Investigational)]; Medibeacon [GFR measurement (Investigational)]; GSK [Anemia (Investigational)]; AMAG [IV irons (Ferumoxytol)]; AstraZeneca [Anemia (Investigational)]."},{"name":"Adam Cuker, MD, MS","credentials":["Assistant Professor of Medicine, Assistant Professor of Pathology & Laboratory Medicine\n","Perelman School of Medicine University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Biogen-Idec, Spark Therapeutics, T2 Biosystems, Shire Pharmaceuticals. Consultant/Advisory Boards: Biogen-Idec, Diagnostica Stago."},{"name":"Rochelle Cunningham, MD","credentials":["Staff Physician\n","Park West Medical Center, Baltimore, MD"],"disclosure":""},{"name":"Gary C Curhan, MD, ScD","credentials":["Section Editor — Chronic Kidney Disease\n","Editor-in-Chief Emeritus\n","Clinical Journal of the American Society of Nephrology\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Allena Pharmaceuticals [Oxalate]. Consultant/Advisory Boards: Allena Pharmaceuticals [Oxalate, nephrolithiasis]; Decibel Therapeutics (Hearing loss/tinnitus); Shire [hypoparathyroidism]; RenalGuard [Acute kidney injury]. Consultant/Advisory Boards (spouse/partner): Decibel Therapeutics (Hearing loss, tinnitus)]. Equity Ownership/Stock Options: Allena Pharmaceuticals. Other Financial Interest: American Society of Nephrology [CJASN Editor-in-Chief]."},{"name":"Vivette D D'Agati, MD","credentials":["Professor of Pathology\n","Columbia University\n","College of Physicians and Surgeons"],"disclosure":""},{"name":"Maria Dall'Era, MD","credentials":["Professor of Medicine\n","University of California, San Francisco"],"disclosure":"Consultant/Advisory Boards: Genentech [Lupus (Rituximab)]."},{"name":"Gabriel Danovitch, MD","credentials":["Distinguished Professor of Medicine\n","University of California, Los Angeles"],"disclosure":""},{"name":"Andrew Davenport, MD, FRCP","credentials":["Director of Dialysis Research\n","UCL Centre for Nephrology\n","University College London"],"disclosure":""},{"name":"Kathryn A Davis, MD, MSTR","credentials":["Assistant Professor of Neurology\n","University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Lundbeck [Epilepsy (Clobazam)]."},{"name":"Sara N Davison, MD, MHSc, FRCP(C)","credentials":["Professor of Medicine\n","University of Alberta"],"disclosure":""},{"name":"Buddhadeb Dawn, MD","credentials":["Maureen and Marvin Dunn Professor\n","University of Kansas Medical Center"],"disclosure":""},{"name":"Bess Dawson-Hughes, MD","credentials":["Senior Scientist and Director\n","Bone Metabolism Laboratory\n","Tufts University"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Vitamin D (Caltrate with vitamin D)]; DSM [Vitamin D (vitamin D)]. Consultant/Advisory Boards: Pfizer [Calcium, general nutrition [Calcium and vitamin D supplement]); Nestle [Nutrition in older adults (Supplement drinks)]; Takeda [Calcium (Calcium supplement)]."},{"name":"Marc E De Broe, MD, PhD","credentials":["Emeritus Professor of Medicine\n","University of Antwerp, Belgium"],"disclosure":""},{"name":"Brian S Decker, MD, PharmD","credentials":["Assistant Professor of Clinical Medicine\n","Indiana University Department of Medicine"],"disclosure":""},{"name":"Christopher deFilippi, MD, FACC","credentials":["Vice Chair of Academic Affairs\n","Inova Heart and Vascular Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Roche Diagnostics [Chronic disease risk stratification (Troponin T, NT-proBNP)]. Consultant/Advisory Boards: Roche Diagnostics [Chronic disease risk stratification (Troponin T)]; Siemens Healthcare Diagnostics [Chronic disease risk stratification (Troponin I)]; Thermo Fisher [Dypnea evaluation (Procalcitonin)]; Ortho Diagnostics [Acute MI diagnosis, acute heart failure diagnosis (Troponin I, NT-proBNP)]; Radiometer [Acute MI diagnosis (Troponin I)]; Metabolomics [Metabolomes (Chronic disease risk stratification)]; Alere [Acute heart failure diagnosis (NT-proBNP)]."},{"name":"Rowena Delos Santos, MD","credentials":["Assistant Professor of Medicine\n","Washington University in St. Louis"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Diabetes (Sitagliptan)]. Equity Ownership/Stock Options (spouse/partner): Pfizer."},{"name":"Michael A DeVita, MD","credentials":["Director of Critical Care Medicine\n","Harlem Hospital Center"],"disclosure":""},{"name":"Kathryn Diemer, MD","credentials":["Associate Professor, Clinical Director, Bone Health Program\n","Division of Bone and Mineral Diseases, Washington University School of Medicine"],"disclosure":"Speaker’s Bureau: Amgen [Osteoporosis (Denosumab)]."},{"name":"Jodie Dionne-Odom, MD","credentials":["Assistant Professor of Medicine\n","Division of Infectious Diseases\n","University of Alabama at Birmingham"],"disclosure":""},{"name":"Angela Dispenzieri, MD","credentials":["Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine, and Pathology\n","Mayo Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer, Celgene, Takeda, Alnylam, Janssen, Prothena (tafamidis, lenalidomide, pomalidomide, ixazomib, bortezomib, NEOD001]."},{"name":"Arjang Djamali, MD, MS, FASN","credentials":["Professor of Medicine and Surgery\n","Head of Nephrology Division\n","Department of Medicine\n","University of Wisconsin School of Medicine and Public Health"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol-Myers Squibb, Takeda-Millennium [Rejection (Belatacept, Ixazomib)]."},{"name":"Pamela S Douglas, MD","credentials":["Ursula Geller Professor of Research in Cardiovascular Diseases\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: National Institutes of Health (NIH) – NHLBI, NCI, NIAID; Columbia University [Diagnostic testing]; Massachusetts General Hospital [Prevention]; Memorial Sloan Kettering Cancer Center [cancer]; City of Hope [cancer]; Bristol Meyers Squibb [Hepatitis C]; GE HealthCare [Diagnostic testing (Optison)]; Gilead [Hepatitis C (Sofosbuvir)]; HeartFlow [CAD diagnosis (FFRCT)]; Singulex; Abbott [biomarkers]; Kowa [prevention]; Verily [genomics]. Grant/Research/Clinical Trial Support (Spouse): National Institutes of Health (NIH) – NHGRI, NIGMS; DARPA; USAMRIID; Abbott; Novartis; Merck; Singulex; US Defense Advanced Research Projects Agency; United States Air Force; Henry Jackson Foundation; Abbott; 23andMe. Consultant/Advisory Boards: Patient Advocate Foundation; General Electric Healthcare DSMB [Heart failure (AdreScan)]; TIMI DSMB [anorexigen]. Consultant/Advisory Boards (Spouse): Alere, Inc; Genome Magazine; CardioDx; Pappas Ventures. Equity Ownership/Stock Options (Spouse): CardioDX; Fabric Genomics; Alere, Inc; Origin Commercial Advisors, LLC; Host Response."},{"name":"Matthew T Drake, MD, PhD","credentials":["Associate Professor of Medicine\n","Mayo Clinic"],"disclosure":""},{"name":"Richard H Drew, PharmD, MS, FCCP, FIDP","credentials":["Professor, Campbell University College of Pharmacy and Health Sciences\n","Associate Professor and Clinical Pharmacist, Infectious Diseases\n","Duke University Medical Center"],"disclosure":"Speaker's Bureau: American Society of Microbiology, Campbell University [Accredited CE programs on various antibiotics, antibiotic stewardship]. Consultant/Advisory Boards: Cidara [Antifungals]. Equity Ownership/Stock Options: CustomID Clinical Decision Support [Equity owner, all antibiotics]."},{"name":"Marc K Drezner, MD","credentials":["Section Editor — Bone Disease\n","Professor of Medicine\n","University of Wisconsin Medical School"],"disclosure":""},{"name":"Brent M Egan, MD","credentials":["Professor of Medicine\n","University of South Carolina School of Medicine-Greenville\n","Chief Science Officer, Care Coordination Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Boehringer [Diabetes (Empagliflozin)]. Speaker's Bureau: Medtronic [Hypertension (Renal artery denervation to lower blood pressure)]; Merck-Sorono [Hypertension, heart failure (Bisoprolol)]; Emcure (clinical epidemiology, pathophysiology, treatment of hypertension). Consultant/Advisory Boards: Valencia [Hypertension (Device-based treatment to lower blood pressure)]; Inside Edge Consulting [Clinical trials (Patient recruitment and retention)]."},{"name":"Georg B Ehret, MD","credentials":["Division of Cardiology\n","Geneva University Hospitals, Switzerland\n","McKusick Institute of Genetic Medicine\n","Johns Hopkins University"],"disclosure":"Consultant/Advisory Boards: Servier Laboratories [Hypertension (Perindopril, amlodipine, indapamide)]; Amgen [Dyslipidemia (Evolocumab)]; Boehringer [Diabetes and hypertension (Empagliflozin)."},{"name":"John F Eidt, MD","credentials":["Section Editor — Vascular and Endovascular Surgery\n","Professor of Surgery, Texas A&M Health Science Center\n","Vice Chair of Vascular Surgical Services, Baylor Heart and Vascular Hospital at Dallas"],"disclosure":""},{"name":"Ghada El-Hajj Fuleihan, MD, MPH","credentials":["Professor of Medicine\n","American University of Beirut Medical Center, Lebanon"],"disclosure":""},{"name":"Carl-Gustaf Elinder, MD, PhD","credentials":["Professor and Senior Consultant of Renal Medicine\n","Karolinska Institute, Sweden"],"disclosure":""},{"name":"William J Elliott, MD, PhD","credentials":["Section Editor — Hypertension\n","Professor of Preventive Medicine, Internal Medicine and Pharmacology\n","Head, Division of Pharmacology\n","Chair, Department of Biomedical Sciences\n","Pacific Northwest University of Health Sciences, Yakima, WA"],"disclosure":"Other Financial Interest: Elsevier; Springer [Hypertension (book, journal)]."},{"name":"David H Ellison, MD, FASN, FAHA","credentials":["Professor of Medicine and Physiology & Pharmacology\n","Oregon Health & Science University"],"disclosure":"Other Financial Interest: Pfizer [Spoke at a sponsored conference on effect of dietary potassium on NCC (Eplerenone)]."},{"name":"Michael Emmett, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Chief of Internal Medicine\n","Baylor University Medical Center"],"disclosure":"Consultant/Advisory Boards: ZS Pharma [Treatment of hyperkalemia (Potassium binder, zirconium silicate)]."},{"name":"Uta Erdbruegger, MD","credentials":["Associate Professor of Medicine\n","University of Virginia"],"disclosure":""},{"name":"Doruk Erkan, MD, MPH","credentials":["Associate Attending Rheumatologist, Hospital for Special Surgery\n","Associate Professor of Medicine, Weill Cornell Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Lupus Clinical Trials Consortium; GlaxoSmithKline [Lupus (Belimumab)]; EMD Serono [lupus]; National Institutes of Health [Antiphospholipid syndrome]; Hospital for Special Surgery Medical Education Academy [Antiphospholipid syndrome]. Consultant/Advisory Boards: GSK (lupus); Ablynx (Antiphospholipid Syndrome)."},{"name":"Ronald J Falk, MD","credentials":["Nan and Hugh Cullman Eminent Professor of Nephrology\n","Chair, Department of Medicine\n","Director, UNC Kidney Center\n","University of North Carolina-Chapel Hill"],"disclosure":""},{"name":"Pedram Fatehi, MD, MPH","credentials":["Assistant Clinical Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Thomas Fekete, MD","credentials":["Professor of Medicine and Microbiology\n","Temple University School of Medicine"],"disclosure":""},{"name":"Adam S Feldman, MD, MPH","credentials":["Assistant Professor of Surgery\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Olympus America, Inc. [Laparoscopy, endourology (Cystoscopy equipment)]."},{"name":"Andrew Z Fenves, MD","credentials":["Associate Professor\n","Harvard Medical School\n","Division of Nephrology and Department of Medicine\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Fernando C Fervenza, MD, PhD","credentials":["Section Editor — Glomerular Diseases \n","Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial support: Genentech [Membranous nephropathy, Fibrillary GN (Rituximab)]; Mallinckrodt [IgA nephropathy] and FSGS(Corticotropin injection gel)]; Janssen Pharmaceutical [Monoclonal protein-mediated renal diseases (Daratumumab)]. Consultant/Advisory Boards: Alexion pharmaceutical [complement-mediated diseases]; Visterra pharmaceutical [complement-mediated diseases]. Employment: Mayo Clinic."},{"name":"Joel S Finkelstein, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Male hypogonadism (Testosterone gel)]."},{"name":"Jay A Fishman, MD","credentials":["Professor of Medicine\n","Harvard Medical School\n","Director, Transplant Infectious Disease and Compromised Host Program\n","Massachusetts General Hospital"],"disclosure":""},{"name":"Steven Flamm, MD","credentials":["Chief, Liver Transplantation Program\n","Professor of Medicine\n","Feinberg School of Medicine\n","Northwestern University"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie, Gilead (HCV). Speaker’s Bureau:\t Abbvie, Gilead, Merck (HCV). Consultant/Advisory Boards: Abbvie, Gilead, Merck (HCV)."},{"name":"John P Forman, MD, MSc","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Nephrology\n","Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Jean Francis, MD","credentials":["Assistant Professor of Medicine\n","Boston University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Alexion; Mallinckrodt [Glomerular disease and aHUS]."},{"name":"Joy L Fridey, MD","credentials":["Regional Medical Director\n","American Red Cross Blood Services, Southern California"],"disclosure":""},{"name":"Jonathan W Friedberg, MD","credentials":["Professor of Medicine\n","James P Wilmot Cancer Center, University of Rochester"],"disclosure":"Consultant/Advisory Boards: Bayer [DSMB for trials (Investigational agents)]; Astellas [DSMB for trials (Acalabrutinib)]."},{"name":"Lawrence S Friedman, MD","credentials":["Section Editor — General Gastroenterology\n","Professor of Medicine\n","Harvard Medical School\n","Tufts University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Consultant, FDA (Antimicrobial Drugs Advisory Committee); Trustee, Newton-Wellesley Hospital (through June 2017). Employment: Boston Health Care for the Homeless. Other Financial Interest: Elsevier [Gastroenterology (Royalties from textbooks)]; McGraw-Hill [Gastroenterology (Royalties from textbooks)]; Wiley [Gastroenterology (Royalties from textbooks)]; American Society for Gastrointestinal Endoscopy [Gastroenterology and hepatology (Honorarium as newsletter editor)]."},{"name":"Daniel E Furst, MD","credentials":["Section Editor — Treatment Issues in Rheumatology\n","Clinical professor, University of Washington, Seattle\n","Clinical professor, University of Florence, Florence, Italy\n","Professor of Rheumatology, University of California in Los Angeles (Emeritus)\n","Director of Research, Pacific Arthritis Associates"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [RA, IBD, PMS, PsA (adalimumab)]; Actelion [SSc (bosentan, macitentan)]; Amgen [RA, IBP, AS, PsA (etanercept)]; BMS [RA, SSc (abatacept)]; Corbus [SSc, SLE (anabasum)]; NIH; Novartis; Pfizer [SSc (sildenafil)]; Roche/Genentech [RA, IBD, AS, SSc (rituximab, tocilizumab)]. Consultant/Advisory Boards: AbbVie [RA, IBD, PMS, PsA (adalimumab)]; Actelion [SSc (bosentan, macitentan)]; Amgen [RA, IBP, AS, PsA (etanercept)]; BMS [RA, SSc (abatacept)]; Cytori [lab test advisory]; Novartis; Pfizer [SSc (sildenafil)]; Roche/Genentech [RA, IBD, AS, SSc (rituximab, tocilizumab)]."},{"name":"James N George, MD","credentials":["Professor of Medicine\n","University of Oklahoma Health Sciences Center"],"disclosure":"Grant/Research/Clinical Trial Support: Ablynx [TTP (caplacizumab)]."},{"name":"Arshia Ghaffari, DO, MA, MBA","credentials":["Assistant Professor Clinical Medicine, Division of Nephrology\n","Keck School of Medicine, University of Southern California"],"disclosure":"Speaker's Bureau: Baxter Healthcare [Peritoneal dialysis (Peritoneal dialysis supplies)]. Consultant/Advisory Boards: DaVita Healthcare Partners [Dialysis services]."},{"name":"Elsa-Grace Giardina, MD, MS, FACC, FACP, FAHA","credentials":["Professor of Medicine\n","Director, Center for Women’s Health \n","Columbia University Medical Center"],"disclosure":""},{"name":"C Michael Gibson, MS, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Atrial fibrillation (Rivaroxaban)]; Janssen Pharmaceuticals [Atrial fibrillation (Rivaroxaban)]; Johnson & Johnson [Atrial fibrillation (Rivaroxaban)]; The Medicines Company [Anticoagulation (Bivalirudin)]; Eli Lilly and Company [Percutaneous coronary intervention (Prasugrel)]."},{"name":"Richard J Glassock, MD, MACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Glomerular Diseases\n","Emeritus Professor\n","The David Geffen School of Medicine at UCLA"],"disclosure":"Speaker's Bureau: Genentech [Vasculitis (Rituximab)]. Consultant/Advisory Boards: Bristol-Myers-Squibb [Lupus nephritis, FSGS (Abatacept)]; ChemoCentryx [Vasculitis, diabetes (Acocapan)]; Retrophin [FSGS(Sparsentan)]. Equity Ownership/Stock Options: Reata (Bardoxolone)."},{"name":"Joel D Glickman, MD","credentials":["Professor of Clinical Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Ary L Goldberger, MD","credentials":["Section Editor — Electrocardiography\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Other Financial Interest: Elsevier book royalties [Clinical electrocardiography]."},{"name":"David S Goldfarb, MD, FACP, FASN","credentials":["Professor of Medicine and Physiology\n","New York University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Allena [Nephrolithiasis (Allena 177)]; Retrophin (Cystinuria (Tiopronin)]. Patent Holder: Ravine Group [Nephrolithiasis, cystinuria]."},{"name":"Stanley Goldfarb, MD","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Mineral and Bone Metabolism; Renal Ureteral Stones\n","Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"David JA Goldsmith, MA, FRCP","credentials":["Visiting Professor\n","St. George's Hospital University Medical School\n","GI Popescu School of Pharmacy and Medicine"],"disclosure":"Speaker's Bureau: Amgen [CKD-MBD (Cinacalcet)]; Vifor [CKD-MBD (Iron sucrose hydroxyoxide)]; Abbvie [CKD-MBD (Paricalcitol)]; Sanofi [CKD-MBD (Sevelamer)]. Consultant/Advisory Board: Amgen [CKD-MBD (Cinacalcet)]; Vifor [CKD-MBD (Iron sucrose hydroxyoxide)]; Abbvie [CKD-MBD (Paricalcitol)]; Sanofi [CKD-MBD (Sevelamer)]."},{"name":"Thomas A Golper, MD","credentials":["Section Editor — Dialysis\n","Professor of Medicine\n","Vanderbilt University Medical Center"],"disclosure":"Consultant/Advisory Board: Keryx [Peritoneal dialysis (Ferric citrate)]."},{"name":"David Goltzman, MD","credentials":["Professor of Medicine\n","McGill University\n","Senior Physician, Division of Endocrinology and Department of Medicine\n","McGill University Health Centre"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen; Eli Lilly; Merck [Osteoporosis]. Consultant/Advisory Boards: Amgen [Osteoporosis (Denosumab)]."},{"name":"Peter D Gorevic, MD","credentials":["Professor of Medicine, Rheumatology\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"Carmen Gota, MD","credentials":["Orthopedic and Rheumatologic Institute at Cleveland Clinic\n","Center for Vasculitis Care and Research at Cleveland clinic"],"disclosure":""},{"name":"Stephen S Gottlieb, MD","credentials":["Section Editor — Heart Failure\n","Professor of Medicine\n","University of Maryland School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Heart failure (Tafamidis)]; Novartis [Heart failure (Serelaxin)]; Respicardia [Sleep apnea (Pacing)]; Amgen [Omecamtiv mecarbil]. Consultant/Advisory Boards: BMS [Heart failure (Natriuretic peptides)]; Cytokinetics [Heart failure (Omecamtiv mecarbil)]."},{"name":"Saul P Greenfield, MD","credentials":["Clinical Professor of Urology, State University of New York at Buffalo School of Medicine & Biomedical Sciences\n","Director of Pediatric Urology, Children’s Hospital of Buffalo"],"disclosure":""},{"name":"Muriel PC Grooteman, MD, PhD","credentials":["Assistant Professor\n","VU University Medical Center, Amsterdam"],"disclosure":"Speaker's Bureau: Baxter Healthcare [Hemodialysis (Dialysis equipment)]; Fresenius Medical Care BV [Hemodialysis (Dialysis equipment)]."},{"name":"Aditi Gupta, MD","credentials":["Assistant Professor\n","University of Kansas Medical Center"],"disclosure":""},{"name":"Kalpana Gupta, MD, MPH","credentials":["Professor of Medicine\n","Boston University School of Medicine\n","Chief, Infectious Diseases\n","Boston VA HCS"],"disclosure":"Consultant/Advisory Boards: Paratek Pharmaceuticals; Melinta Therapeutics; Iterum Therapeutics; Tetraphase Pharmaceuticals; Ocean Spray Inc. [UTI]."},{"name":"Laurie Gutmann, MD","credentials":["Professor and Vice Chair of Clinical Research\n","University of Iowa"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion [Myasthenia gravis (Eculizumab)]."},{"name":"Robert G Hahn, MD, PhD","credentials":["Professor of Anesthesiology\n","The University of Linköping, Sweden\n","Associate Professor\n","Karolinska Institutet, Stockholm, Sweden"],"disclosure":""},{"name":"Patrick J Hanly, MD, FRCPC, MRCPI,  DABSM","credentials":["Professor of Medicine\n","University of Calgary, Canada"],"disclosure":"Grant/Research/Clinical Trial Support: Philips Respironics [Sleep apnea (Continuous positive airway pressure)]. Employment: Dream Sleep Respiratory Services [Interpretation of ambulatory sleep studies]."},{"name":"Karen Hardinger, PharmD, BCPS","credentials":["Clinical Professor\n","University of Missouri-Kansas City"],"disclosure":""},{"name":"Lee A Hebert, MD","credentials":["Section Editor — Glomerular Diseases \n","Professor of Medicine\n","Ohio State University \n","Wexner College of Medicine and Public Health"],"disclosure":"Consultant/Advisory Boards: Best Doctors in America [Glomerular diseases]; ARDEA [Uricosuric drug]; Alexion [Eculizumab]."},{"name":"William L Henrich, MD, MACP","credentials":["Professor of Medicine\n","President of the Health Science Center\n","University of Texas Health Science Center School of Medicine"],"disclosure":""},{"name":"Charles A Herzog, MD","credentials":["Professor of Medicine\n","Hennepin County Medical Center/University of Minnesota"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Pharmaceuticals for anemia, cardiovascular disease, CKD (Epoetin, darbepoetin, evolocumab, ivabradine)]; Peer Kidney Care Initiative [dialysis care]; Relypsa [Pharmaceuticals, hypo- and hyperkalemia (multiple drugs)]; Zoll [Sudden cardiac death, medical devices (Wearable external cardioverter defibrillator)]. Consultant/Advisory Boards: AbbVie [Diabetes mellitus II, SONAR study (Atrasentan)]; Fibrogen/DSMB [Pharmaceuticals, anemia (Experimental drug)]; KBP Biosciences [Pharmaceuticals, cardiovascular disease]; OxThera [Pharmaceuticals, experimental drug];  Relypsa [Pharmaceuticals, hyperkalemia (Patiromer)]; Sanifit [Pharmaceuticals, mineral bone disease (experimental drug)]. Equity Ownership/Stock Options: Boston Scientific [Medical devices (Defibrillators)]; GE [Medical devices, echo contrast]; Merck [Pharmaceuticals]; Johnson & Johnson [Pharmaceuticals, medical devices]."},{"name":"Tamara Hew-Butler, DPM, PhD","credentials":["Associate Professor, Exercise Science\n","Oakland University"],"disclosure":""},{"name":"Patricia L Hibberd, MD, PhD","credentials":["Chair, Department of Global Health\n","Boston University School of Public Health"],"disclosure":""},{"name":"Karl F Hilgers, MD","credentials":["Professor of Internal Medicine and Hypertension Research\n","Friedrich-Alexander University, Erlangen-Nuremberg\n","Vice Chair, Department of Nephrology and Hypertension\n","Erlangen University Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas; Novartis [Kidney transplantation (Tacrolimus, sirolimus, everolimus)]."},{"name":"Irl B Hirsch, MD","credentials":["Section Editor — Diabetes Mellitus\n","Professor of Medicine\n","University of Washington School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Medtronic [Diabetes (Insulin pump/sensor). Consultant/Advisory Boards: Abbott [Diabetes (Blood glucose meters)]; Adocia [Diabetes (insulin)]; Roche [Diabetes (Blood glucose meters)]; Bigfoot Biomedical [Diabetes (Insulin pump)]."},{"name":"Nicholas Hoenich, PhD","credentials":["Associate Member\n","Institute of Cellular Medicine, Newcastle University"],"disclosure":""},{"name":"Jonathan Hogan, MD","credentials":["Assistant Professor of Medicine\n","Perelman School of Medicine at the University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Dimerix [Glomerular disease]; Aurinia [Glomerular disease]; Variant [Glomerular disease]."},{"name":"Jean L Holley, MD, FACP","credentials":["Clinical Professor of Medicine\n","University of Illinois, Urbana-Champaign"],"disclosure":""},{"name":"Ewout J Hoorn, MD, PhD","credentials":["Professor of Nephrology\n","Erasmus Medical Center, Rotterdam, The Netherlands"],"disclosure":""},{"name":"Robert Hootkins, MD, PhD, FACP, FAHA, FASN","credentials":["Clinical Associate Professor of Medicine \n","University of Texas Southwestern"],"disclosure":"Consultant/Advisory Board: Fresenius Medical Care [Consultant to the CMO]; Baxter Healthcare [legal consultant]; Novadiol [(chronic kidney disease (CKD) patients with secondary hyperparathyroidism (SHPT)]."},{"name":"Thomas M Hooton, MD","credentials":["Professor of Medicine\n","University of Miami Miller School of Medicine"],"disclosure":"Consultant/Advisory Boards: Cubist [Complicated UTI (Ceftolozane/tazobactam)]; Danone [UTI management (Hydration therapy)]; GSK (Antimicrobial in development); Ocean Spray (Cranberry products); Paratek Pharmaceuticals (Antimicrobial in development). Equity Ownership/Stock Options: Fimbrion Therapeutics [UTI prevention (Development of mannosides)]."},{"name":"William Hopkins, MD","credentials":["Associate Professor of Medicine\n","University of Vermont College of Medicine"],"disclosure":""},{"name":"Lesley D Hordon, MD","credentials":["Consultant in Rheumatology\n","University of Leeds, United Kingdom"],"disclosure":""},{"name":"Mara J Horwitz, MD","credentials":["Assistant Professor of Medicine\n","University of Pittsburgh"],"disclosure":""},{"name":"Chi-yuan Hsu, MD, MSc","credentials":["Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Edmund Huang, MD","credentials":["Associate Professor of Medicine\n","University of California, Los Angeles School of Medicine\n","Cedars-Sinai Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: CareDx [Noninvasive Diagnosis of Rejection (AlloSure)]. Other Financial Interest: ThermoFischer [honorarium for lecture]."},{"name":"Gene G Hunder, MD","credentials":["Section Editor — Vasculitis\n","Emeritus Consultant\n","Professor Emeritus\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Lesley A Inker, MD, MS","credentials":["Associate Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Olav Istre, MD, PhD","credentials":["Professor, Deptartment of  Obstetrics and Gynecology\n","South Danish University\n","Odense, Denmark"],"disclosure":""},{"name":"Bernard G Jaar, MD, MPH, FASN","credentials":["Assistant Professor of Medicine and Epidemiology\n","Associate Faculty, Welch Center for Prevention, Epidemiology and Clinical Research\n","Johns Hopkins Medical Institutions\n","Nephrology Center of Maryland"],"disclosure":""},{"name":"Bertrand L Jaber, MD, MS, FASN","credentials":["Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Opsonix [Sepsis]."},{"name":"Anuja Java, MD","credentials":["Instructor in Medicine\n","Washington University School of Medicine"],"disclosure":""},{"name":"Kenar D Jhaveri, MD","credentials":["Professor of Medicine\n","Associate Chief, Division of Kidney Diseases and Hypertension\n","Zucker School of Medicine at Hofstra/Northwell"],"disclosure":""},{"name":"Eric Jonasch, MD","credentials":["Professor\n","The University of Texas MD Anderson Cancer Center"],"disclosure":"Grant/Research/Clinical Trial Support: Exelixis; Novartis; Pfizer [Kidney cancer (Pazopanib, cabozantinib, sunitinib)]. Consultant/Advisory Boards: BMS; Exelixis; Esai; Novartis; Pfizer [Kidney cancer (Nivolumab, everolimus, pazopanib, temsirolimus, cabozantinib, sunitinib, lenvatinib)]."},{"name":"Lynne C Jones, PhD","credentials":["Associate Professor, Orthopaedic Surgery\n","Director, Center for Osteonecrosis Research and Education\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Harald Jüppner, MD","credentials":["Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Pradeep V Kadambi, MD, MBA, FASN, FAST","credentials":["Professor\n","Department of Medicine\n","University of Florida College of Medicine – Jacksonville\n","Senior Associate Dean for Clinical Affairs\n","University of Florida College of Medicine – Jacksonville\n","President and CEO\n","University of Florida Jacksonville Physicians, Inc"],"disclosure":"Speaker's Bureau: Alexion [TMA (Eculizumab)]. Consultant/Advisory Boards: Alexion [TMA (Eculizumab)]."},{"name":"Kamyar Kalantar-Zadeh, MD, MPH, PhD","credentials":["Professor & Chief, Division of Nephrology & Hypertension \n","University of California Irvine, School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [(CKD, ESRD, nutrition, bone and minerals (Lanthanum)]. Speaker's Bureau: Abbott; Abbvie; Amgen; Fresenius; Otsuka; Shire [(CKD, renal nutrition, anemia, bone and minerals, hyponatremia (Medical nutrition, paricalcitol, cinacalcet, tolvaptan, Lanthanum)]. Consultant/Advisory Boards: Baxter; Fresenius; Hospira; Kyrex; Reseverlogic; Rockwell; Vifor [PD, CKD, anemia, acid-base, phosphorus binder, iron therapy (PD minicaps, dialysate acid, biosimilars, new phosphorus binders, new iron agents)]."},{"name":"Raghu Kalluri, MD, PhD","credentials":["Professor, Department of Cancer Biology\n","Chair, Department of Cancer Biology\n","The University of Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Nassim Kamar, MD, PhD","credentials":["Department of Nephrology and Organ Transplantation\n","Toulouse University Hospital, France"],"disclosure":"Other Financial Interest (one-time lecture fees): Gilead Sciences [HCV (Sofosbuvir)]; MSD [HCV (Grazoprevir/Elbasvir)]; Abbvie [HCV (Ombitasvir/Paritaprévir/Ritonavir/Glecaprevir-pibrentasvir)]."},{"name":"Andre A Kaplan, MD","credentials":["Professor of Medicine\n","University of Connecticut Health Center"],"disclosure":"Grant/Research/Clinical Trial Support: Nipro Corporation [Dialysis (Dialysis filters)]. Speaker's Bureau: Terumo [Plasmapheresis (Plasmapheresis machines)]. Consultant/Advisory Boards: Vital Therapeutics [Extracorporeal liver assist device (ELAD)]."},{"name":"Norman M Kaplan, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Hypertension\n","Clinical Professor of Internal Medicine\n","University of Texas Southwestern Medical Center"],"disclosure":""},{"name":"S Ananth Karumanchi, MD","credentials":["Professor of Medicine, Obstetrics and Gynecology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Thermofisher Scientific [Preeclampsia (Biomarkers in preeclampsia)]. Patent Holder: Beth Israel Deaconess Medical Center [Preeclampsia (Co-inventor on patents related to preeclampsia biomarkers)]. Equity Ownership/Stock Options: Aggamin Therapeutics [Preeclampsia (Novel therapies in preeclampsia)]. Other Financial Interest: Alnylam Therapeutics [Hypertension (RNA-based therapies)]."},{"name":"Clifford E Kashtan, MD","credentials":["Professor of Pediatrics\n","Director, Division of Pediatric Nephrology\n","University of Minnesota Medical School\n","Executive Director\n","Alport Syndrome Treatments and Outcomes Registry (ASTOR)"],"disclosure":"Grant/Research/Clinical Trial Support: Regulus Therapeutics [Anti-microRNA therapies (Anti-microRNA-21)]; Reata Pharmaceuticals [Chronic kidney disease (Bardoxolone)]; Novartis Institute for Biomedical Research [Urinary biomarkers]."},{"name":"Carol A Kauffman, MD","credentials":["Editor-in-Chief — Infectious Diseases\n","Section Editor — Fungal Infections\n","Professor of Internal Medicine\n","University of Michigan Medical School\n","Veterans Affairs Ann Arbor Healthcare System"],"disclosure":""},{"name":"Jonathan Kay, MD","credentials":["Timothy S. and Elaine L. Peterson Chair in Rheumatology\n","Professor of Medicine and Director of Clinical Research, Rheumatology\n","University of Massachusetts Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences; Pfizer [Felty's syndrome, rheumatoid arthritis (Infliximab-dyyb, tofacitinib)]; UCB [Felty's syndrome, rheumatoid arthritis (Certolizumab pegol)]. Consultant/Advisory Boards: Amgen [Felty's syndrome, rheumatoid arthritis (Adalimumab-atto, etanercept, filgrastim)]; Boehringer Ingelheim [Felty's syndrome, rheumatoid arthritis]; Celgene; Celltrion Healthcare [Felty's syndrome, rheumatoid arthritis (Infliximab-dyyb)]; Janssen Biotech [Felty's syndrome, rheumatoid arthritis [Infliximab]); Merck [Felty's syndrome, rheumatoid arthritis]; Myriad Genetics [Felty's syndrome, rheumatoid arthritis]; Pfizer [Felty's syndrome, rheumatoid arthritis (Infliximab-dyyb, tofacitinib)]; Roche Laboratories [Felty's syndrome, rheumatoid arthritis (Rituximab, tocilizumab)]; Samsung Bioepis [Felty's syndrome, rheumatoid arthritis]; Sandoz [Felty's syndrome, rheumatoid arthritis (Etanercept-szzs, filgrastim-sndz)]."},{"name":"Electron Kebebew, MD, FACS","credentials":["Senior Investigator\n","Chief, Endocrine Oncology Branch\n","National Cancer Institute\n","Professor of Surgery\n","George Washington University School of Medicine & Health Sciences"],"disclosure":""},{"name":"Ellie Kelepouris, MD, FAHA","credentials":["Professor of Medicine\n","Chief, Division of Nephrology and Hypertension\n","Drexel University College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Mallinkrodt [Nephrotic syndrome (ACTHar gel)]; Relypsa [Hyperkalemia (Veltassa)];  Mallinkdrodt [Proteinuria (ACTHar gel)]; Mallinkrodt [Proteinuria ACTHar gel)]. Consultant/Advisory Boards: Relypsa [Hyperkalemia (Veltassa)]."},{"name":"Ramesh Khanna, MD, FACP","credentials":["Karl D Nolph, MD Chair in Nephrology, Professor of Medicine\n","Vice Chair, Department of Medicine\n","Director, Division of Nephrology\n","University of Missouri-Columbia"],"disclosure":""},{"name":"Jan T Kielstein, MD, FASN, FERA","credentials":["Assistant Professor of Medicine, Hannover Medical School, Hannover, Germany\n","Director Medical Clinic V (Nephrology, Rheumatology, Blood Purification), Academic Teaching Hospital, Braunschweig, Germany"],"disclosure":""},{"name":"Talmadge E King, Jr, MD","credentials":["Editor-in-Chief — Pulmonary and Critical Care Medicine\n","Section Editor — Interstitial Lung Disease\n","Dean, School of Medicine \n","Vice Chancellor, Medical Affairs\n","University of California San Francisco"],"disclosure":""},{"name":"Christina L Klein, MD","credentials":["Transplant Nephrologist\n","Piedmont Transplant Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [CMV (CMV vaccine)]; Chimerix [CMV (Brincidofovir)]. Speaker's Bureau: Alexion [Atypical HUS (Eculizumab)]. Consultant/Advisory Boards: Alexion [Atypical HUS (Eculizumab)]."},{"name":"Paul E Klotman, MD","credentials":["President, CEO, and Executive Dean\n","Baylor College of Medicine"],"disclosure":"Consultant/Advisory Boards: 98point6 [Clinical decision-making support]. Consultant/Advisory Boards (spouse/partner): 98point6 [Clinical decision-making support]. Equity Ownership/Stock Options: 98point6 [Clinical decision-making support]. Equity Ownership/Stock Options (spouse/partner): 98point6 [Clinical decision-making support]."},{"name":"Sidney M Kobrin, MD","credentials":["Associate Professor of Medicine\n","University of Pennsylvania"],"disclosure":""},{"name":"Robb D Kociol, MD","credentials":["Associate Director\n","Advanced Heart Failure program\n","Beth Israel Deaconess Medical Center\n","Instructor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Holly M Koncicki, MD","credentials":["Assistant Professor \n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"Tal Kopel, MD","credentials":["Assistant Professor of Medicine\n","Centre Hospitalier de l'Université de Montréal"],"disclosure":""},{"name":"Jeffrey B Kopp, MD","credentials":["Senior Investigator, NIDDK, NIH\n","Adjunct Professor of Medicine, Uniformed Services University of the Health Sciences"],"disclosure":""},{"name":"Joel D Kopple, MD","credentials":["Professor of Medicine and Public Health\n","David Geffen School of Medicine at UCLA and UCLA Fielding School of Public Health\n","Los Angeles Biomedical Research Institute at Harbor - UCLA Medical Center"],"disclosure":"Speaker's Bureau: Fresenius Kabi [Low protein diets (Ketoacid supplements)]; Chugai Pharmaceuticals [Renal nutrition]. Consultant/Advisory Boards: Nephroceuticals; Fresenius Kabi [Vitamins]. Equity Ownership/Stock Options: Nephroceuticals [Vitamins for chronic kidney disease (Multivitamin tablets)]."},{"name":"Stephen M Korbet, MD","credentials":["Professor of Medicine\n","Rush University Medical Center"],"disclosure":""},{"name":"Peter Kotanko, MD","credentials":["Docent of Internal Medicine\n","Innsbruck Medical University, Austria\n","Research Director\n","Renal Research Institute, New York"],"disclosure":"Employment: Renal Research Institute [Nephrology (Dialysis)]. Equity Ownership/Stock Options: Fresenius Medical Care [Dialysis (Dialysis equipment)]."},{"name":"Eugene C Kovalik, MD","credentials":["Associate Professor of Medicine\n","Duke University Medical Center"],"disclosure":""},{"name":"Csaba P Kovesdy, MD, FASN","credentials":["Professor of Medicine\n","University of Tennessee Health Science Center"],"disclosure":""},{"name":"Michelle W Krause, MD, MPH","credentials":["Professor of Medicine\n","University of Arkansas for Medical Sciences"],"disclosure":""},{"name":"Jonathan B Kruskal, MD, PhD","credentials":["Section Editor — Kidney Disease\n","Professor of Radiology\n","Harvard Medical School"],"disclosure":""},{"name":"Abhijit V Kshirsagar, MD, MPH","credentials":["Associate Professor of Medicine\n","University of North Carolina at Chapel Hill"],"disclosure":""},{"name":"Aleksandra Kukla, MD","credentials":["Associate Professor of Medicine\n","University of Minnesota"],"disclosure":""},{"name":"Michael Kurtz, MD","credentials":["Instructor in Surgery\n","Children's Hospital Boston"],"disclosure":""},{"name":"Shana Kusin, MD","credentials":["Assistant Professor of Emergency Medicine and Medical Toxicology\n","Oregon Health and Science University"],"disclosure":""},{"name":"Christopher H Kwoh, MD","credentials":["The Kidney Institute and Renal Research, Inc."],"disclosure":""},{"name":"Robert A Kyle, MD","credentials":["Section Editor — Plasma Cell Disorders\n","Professor of Medicine\n","Mayo Medical School"],"disclosure":"Consultant/Advisory Boards: Celgene Disease Monitoring Committee [Dysproteinemias (lenalidomide, pomalidomide)]; Bristol-Myers Squibb Independent Monitoring Committee [Dysproteinemias (elotuzumab)]; Onyx Pharma (Amgen) Data Monitoring Committee [Dysproteinemias (carfilzomib)]; Pharmacyclics Data Safety Monitoring Board [Dysproteinemias (ibrutinib)]. Other Financial Interest: Pfizer [Lecture on therapy of multiple myeloma, made comments concerning a new Pfizer product and received an honorarium]."},{"name":"Albert Q Lam, MD","credentials":["Deputy Editor — Nephrology\n","Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Richard A Larson, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Leukemia\n","Professor of Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [leukemia (gilteritinib)]; Erytech [leukemia (eryaspase)]; Novartis [leukemia (nilotinib, ascininib)]; Daiichi Sankyo [leukemia (quizartinib)]; Celgene [leukemia (enasidenib)]. Consultant/Advisory Boards: Novartis [leukemia (imatinib, nilotinib)]; Ariad Data Safety Monitoring Board [leukemia (ponatinib)]; CVS/Caremark [leukemia (drug prior authorization program)]; Celgene Data Safety Monitoring Board [leukemia (azacitidine, durvalumab)]; Amgen [leukemia (blinatumomab)]; Astellas [leukemia (gilteritinib)]; Jazz [leukemia (CPX-351)]."},{"name":"Geoffrey Lee, MD","credentials":["Attending Physician\n","Kingston General Hospital"],"disclosure":""},{"name":"Michael D Leise, MD","credentials":["Assistant Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Hepatitis C (Grazoprevir, elbasvir)]; Abbvie [Hepatitis C (Glecaprevir/Pibrentasvir)]."},{"name":"Krista L Lentine, MD, PhD","credentials":["Professor of Medicine\n","Saint Louis University School of Medicine"],"disclosure":"Equity Ownership/Stock Options: XynManagement [Risk assessment software for transplant programs]."},{"name":"Edgar V Lerma, MD, FACP, FASN, FAHA","credentials":["SGIM Peer Reviewer\n","Clinical Professor of Medicine\n","University of Illinois at Chicago College of Medicine"],"disclosure":""},{"name":"Nelson Leung, MD","credentials":["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Omeros Corporation [thrombotic microangiopathy]. Consultant/Advisory Boards: Prothena [amyloidosis]; Thrasos Therapeutics [myeloma kidney (cast nephropathy)]."},{"name":"Andrew S Levey, MD","credentials":["Dr. Gerald J. and Dorothy R. Friedman Professor Emeritus\n","Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH, NKF (CKD/GFR); Astra Zeneca (DSMB). Patent Holder: Provisional patent [Coresh, Inker, Levey] titled, “Precise estimation of glomerular filtration rate from multiple biomarkers”, filed 8/15/2014. The technology is not licensed in whole or in part to any company. Tufts Medical Center, John Hopkins University and Metabolon Inc have a collaboration agreement to develop a product to estimate GFR from a panel of markers."},{"name":"E Michael Lewiecki, MD","credentials":["Director\n","New Mexico Clinical Research & Osteoporosis Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Osteoporosis (Denosumab, romosozumab). Speaker's Bureau: Radius [Osteoporosis (Abaloparatide)]. Consultant/Advisory Boards: Amgen [Osteoporosis (Denosumab, romosozumab); Radius [Osteoporosis (Abaloparatide)]."},{"name":"Orfeas Liangos, MD, FASN","credentials":["Adjunct Assistant Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"John C Lieske, MD","credentials":["Professor of Medicine\n","Mayo Clinic Division of Nephrology and Hypertension"],"disclosure":""},{"name":"Kee-Hak Lim, MD","credentials":["Associate Professor of Obstetrics & Gynecology (part-time)\n","Harvard Medical School"],"disclosure":""},{"name":"Ajit P Limaye, MD, FACP, FIDSA","credentials":["Professor of Medicine\n","University of Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [BKV infection (Antibodies)]."},{"name":"Robert M Lindsay, MD, FRCPC, FRCPE","credentials":["Professor, Schulich School of Medicine\n","Western University, London, Canada"],"disclosure":""},{"name":"Cornelis J Lips, MD, PhD","credentials":["Professor of Endocrinology and Metabolism\n","Department of Internal Medicine\n","University Medical Center Utrecht, The Netherlands"],"disclosure":""},{"name":"Mark Little, FRCP, PhD","credentials":["Professor of Nephrology\n","Trinity College Dublin"],"disclosure":""},{"name":"Anna SF Lok, MD","credentials":["Professor of Medicine\n","University of Michigan Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead [HBV/HCV]; Bristol-Myers Squibb [HCV]; Merck [HCV]; Target Pharma [NAFL]."},{"name":"Randy Luciano, MD, PhD","credentials":["Instructor in Medicine\n","Yale University Medical School"],"disclosure":""},{"name":"Naim Maalouf, MD","credentials":["Associate Professor of Medicine\n","University of Texas Southwestern Medical Center"],"disclosure":"Other Financial Interest: Quest Diagnostics [Osteoporosis (Educational webinar)]."},{"name":"Colm C Magee, MD, MPH, FRCPI","credentials":["Clinical Lecturer in Medicine\n","Royal College of Surgeons"],"disclosure":"Other Financial Interest: Astellas [Conference support/hotel (American Transplant Congress)]."},{"name":"Lionel U Mailloux, MD, FACP","credentials":["Clinical Professor of Medicine\n","Hofstra Northwell School of Medicine"],"disclosure":""},{"name":"Andrew Malone, MB, BCh, MRCPI","credentials":["Assistant Professor of Medicine, Division of Nephrology\n","Department of Medicine, Washington University School of Medicine"],"disclosure":""},{"name":"Jess Mandel, MD","credentials":["Section Editor — Pulmonary Vascular Disease\n","Professor of Medicine\n","University of California, San Diego"],"disclosure":""},{"name":"J Michael Mangrum, MD","credentials":["Associate Professor of Medicine\n","University of Virginia"],"disclosure":""},{"name":"Johannes FE Mann, MD","credentials":["Professor of Medicine\n","Friedrich Alexander University of Erlangen-Nürnberg\n","International Scholar, Population Health Research Institute, McMaster University, Canada"],"disclosure":"Grant/Research/Clinical Trial Support: NovoNordisk [Diabetes (insulin, liraglutide)]; European Union [diabetes]; Celgene [anemia, bone disease]; Roche [anemia]; Vifor [hyperkalemia (patiromer)]; Relypsa [hyperkalemia (patiromer)]. Speaker's Bureau: Astra [hyperkalemia]; Braun [dialysis]; Fresenius [dialysis]; Gambro [dialysis]; Medice [dialysis]; NovoNordisk [diabetes]; Relypsa [hyperkalemia]; Roche [anemia]; Boehringer [diabetes]. Consultant/Advisory Boards: Abbvie [diabetes]; Astra [hyperkalemia, diabetes]; Celgene [anemia]; Fresenius [dialysis]; Lilly [diabetes]; NovoNordisk [diabetes]; Relypsa [hyperkalemia]; Sanofi [diabetes]; Vifor [hyperkalemia]."},{"name":"Samuel J Mann, MD","credentials":["Professor of Clinical Medicine\n","Division of Nephrology and Hypertension\n","NY Presbyterian Hospital – Weill Cornell Medical College"],"disclosure":""},{"name":"Warren J Manning, MD","credentials":["Section Editor — Noninvasive Cardiac Imaging and Stress Testing\n","Professor of Medicine and Radiology\n","Harvard Medical School"],"disclosure":"Patent Holder: Samsung Electronics [MRI]. Equity Ownership/Stock Options: Pfizer [Anticoagulants]. Equity Ownership/Stock Options (Spouse): General Electric [Cardiac imaging]."},{"name":"Stavros C Manolagas, MD, PhD","credentials":["Professor of Medicine\n","University of Arkansas for Medical Sciences"],"disclosure":"Ownership/Stock Options: Radius Health [Osteoporosis therapy (Abaloparatide)]."},{"name":"Glen S Markowitz, MD","credentials":["Professor of Clinical Pathology\n","Columbia University Medical Center"],"disclosure":""},{"name":"Philip A Marsden, MD","credentials":["Professor of Medicine\n","Vice-Chair, Department of Medicine at the University of Toronto, Research\n","Oreopoulos-Baxter Division Director of Nephrology at the University of Toronto"],"disclosure":""},{"name":"Tej K Mattoo, MD, DCH, FRCP","credentials":["Section Editor — Pediatric Nephrology\n","Professor of Pediatrics\n","Wayne State University School of Medicine"],"disclosure":""},{"name":"Michael Mauer, MD","credentials":["Professor of Pediatrics and Medicine\n","University of Minnesota Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Sanofi/Genzyme; Amicus [Fabry disease (Agalsidase beta, migalastat). Consultant/Advisory Boards: Sanofi/Genzyme [Fabry disease (Agalsidase beta)]; Amicus [Fabry disease (migalastat)]."},{"name":"Ivan D Maya, MD, FACP","credentials":["Associate Professor of Medicine\n","University of Central Florida"],"disclosure":""},{"name":"David K McCulloch, MD","credentials":["Diabetologist\n","Washington Permanente Medical Group"],"disclosure":""},{"name":"W. Joseph McCune, MD, MACR","credentials":["Michael H and Marcia S Klein Professor of Rheumatic Diseases\n","Associate Chief, Division of Rheumatology\n","Director, Lupus Program\n","University of Michigan"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Lupus (Anifrolumab)]; Eli Lilly [Lupus (Baricitinab)]; GlaxoSmithKline [Lupus (Belimumab)]."},{"name":"Colin McDonald, MD","credentials":["Instructor in Neurology\n","Harvard Medical School"],"disclosure":"Equity Ownership/Stock Options: Specialists on Call [Medical Management (Emergency Neurology Telemedicine)]."},{"name":"Ankit Mehta, MD","credentials":["Assistant Professor, Department of Internal Medicine, Texas A&M College of Medicine, Dallas\n","Associate Program Director, Internal Medicine Residency, Baylor University Medical Center, Dallas"],"disclosure":""},{"name":"James B Meigs, MD, MPH","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Jaime R Merchan, MD, MMSc","credentials":["Associate Professor of Medicine\n","University of Miami Miller School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Agensys [Cancer (ASG-22CE)]; Rexahn Pharmaceuticals [Cancer (RX-3117)]; Lilly [Cancer (LY3039478)]; Tracon [Cancer (TRC105)]; Acceleron [Cancer (Dalantarcept)]; Novartis [Cancer (Trametinib/ribociclib)]. Consultant/Advisory Boards: Exelixis [Cancer (cabozantinib)]."},{"name":"Angelo Mercieri, MD","credentials":["Internal Medicine Unit\n","Head Physician of Emergencies Unit\n","Bolognini Hospital, Seriate, Bergamo, Italy"],"disclosure":""},{"name":"Peter A Merkel, MD, MPH","credentials":["Section Editor — Vasculitis\n","Chief, Division of Rheumatology\n","University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Actelion [scleroderma]; Bristol-Myers Squibb [vasculitis (abatacept)]; Celgene [vasculitis (apremilast)]; ChemoCentryx [vasculitis (avocopan)]; Genentech/Roche [vasculitis (rituximab, tocilizumab)]; GlaxoSmithKline [vasculitis (belimumab, mepolimumab, sirukumab)]; Kypha [vasculitis]; MedImmune [vasculitis]; TerumoBCT [vasculitis]. Consultant/Advisory Boards: Abbvie [vasculitis]; Actelion [scleroderma]; Bristol-Myers Squibb [vasculitis]; Beoringher Ingelheim [scleroderma]; ChemoCentryx [vasculitis (avocopan)]; Genentech/Roche[vasculitis (rituximab, tocilizumab)]; GlaxoSmithKline [vasculitis (belimumab, mepolimumab)]; InflaRx [vasculitis]; PrincipiaBio [vasculitis]; Prothena [vasculitis]; Seattle Genetics [vasculitis]."},{"name":"Joseph F Merola, MD, MMSc, FAAD, FACR","credentials":["Assistant Professor, Harvard Medical School\n","Department of Dermatology\n","Department of Medicine, Division of Rheumatology \n","Brigham and Women's Hospital"],"disclosure":"Grant/Research Support: Biogen [Cutaneous lupus erythematosus]; Pfizer [Psoriatic arthritis (Tofacitinib)]; Boehringer Ingelheim Pharmaceuticals [Psoriasis (Ustekinumab)]; Eli Lily and Company [Psoriasis (Ixekizumab)]. Speakers Bureau: AbbVie [Psoriasis (Adalimumab)]. Consultant/Advisory Boards: Biogen [Cutaneous lupus erythematosus]; AbbVie [Psoriasis, psoriatic arthritis (Adalimumab)]; Amgen [Psoriasis, psoriatic arthritis (Etanercept)]; Eli Lilly and Company [Psoriasis, psoriatic arthritis (Tofacitinib)]; Novartis [Psoriasis, psoriatic arthritis (Secukinumab)]; Pfizer [Psoriasis, psoriatic arthritis (Tofacitinib)]; Janssen Pharmaceutica [Psoriasis, psoriatic arthritis (Ustekinumab)]; Momenta Pharmaceuticals [Connective tissue disease]; Mallinckrodt Pharmaceuticals [Psoriasis, psoriatic arthritis (Repository corticotropin injection)]. Patent Holder: AbbVie [Psoriasis (Licensed outcome measure)]."},{"name":"Theo E Meyer, MD, PhD","credentials":["Professor of Medicine \n","Chief, Clinical Cardiology \n","Director, Advanced Heart Failure Program \n","University of Massachusetts Medical School \n","UMassMemorial Medical Center"],"disclosure":""},{"name":"Alain Meyrier, MD","credentials":["Professor of Medicine (Emeritus)\n","Université Paris-Descartes, Paris, France"],"disclosure":""},{"name":"Brent W Miller, MD","credentials":["Professor of Medicine\n","Washington University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Fresenius Medical Care [Dialysis (Dialysis centers, equipment, and supplies)]."},{"name":"Paul D Miller, MD","credentials":["Distinguished Clinical Professor of Medicine\n","University of Colorado Health Sciences Center"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion; Amgen; Boehringer Ingelheim; Immunodiagnostics; Eli Lilly & Company; Merck; Merck Serrano; National Bone Health Alliance; Novartis; Radius Pharma; Roche Diagnostics; Regeneron; Ultragenyx [Osteoporosis, Osteoarthritis, HPP, TIO, Type II diabetes, Fracture studies, Renal bone disease]. Consultant/Advisory Boards/ Data Safety Committee: Allergan Pharmaceuticals; Grünenthal Group; Amgen; AgNovos; Lilly; Merck; Radius Pharma; Roche; Ultragenyx [Osteoporosis, Osteoarthritis, HPP, TIO, Osteogenesis imperfect, Renal bone disease, Bone in type II diabetes]."},{"name":"Dana Miskulin, MD","credentials":["Associate Professor\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Madhukar Misra, MD, FRCP","credentials":["Professor of Medicine\n","University of Missouri School of Medicine, Columbia"],"disclosure":""},{"name":"Bruce A Molitoris, MD","credentials":["Professor of Medicine\n","Indiana University School of Medicine"],"disclosure":"Patent Holder: La Jolla Pharmaceuticals [Gentamicin (Nontoxic gentamicin congener)]."},{"name":"Michael A Mont, MD","credentials":["Chair, Orthopaedic Surgery\n","Cleveland Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: DJO Global [Osteoarthritis (braces)]; Johnson and Johnson [Sutures]; National Institutes of Health [Prostheses explant]; Ongoing Care Solutions [Osteoarthritis (Braces)]; Orthosensor [Joint replacement sensor]; Stryker [Joint replacement prostheses]; TissueGene [Osteoarthritis (TissueGene-C)]. Consultant/Advisory Boards: DJO Global [Osteoarthritis (braces)]; Johnson and Johnson [Sutures]; Orthosensor [Joint replacement sensor]; Pacira [Pain control (Liposomal bupivacaine)]; Sage [Infection prevention (Chlorhexidine cloth)]; Stryker [Joint replacement prostheses]; Mallinckrodt Pharmaceuticals [Pain control medication]; Abbott [Medications]. Other financial interest: Microport [IP royalties]; Stryker [IP royalties]."},{"name":"James P Morgan, MD, PhD","credentials":["Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"R Sean Morrison, MD","credentials":["Section Editor — Selected End Stage Conditions\n","Hermann Merkin Professor of Palliative Care\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"David B Mount, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Ardea [Urate transport (Lesinurad)]. Consultant/Advisory Boards: ZS Pharma [Potassium (ZS9)]; Relypsa [Potassium (Patiromer)]."},{"name":"Marion Muche, MD","credentials":["Charité - Medical University, Berlin, Germany"],"disclosure":""},{"name":"Istvan Mucsi, MD, PhD","credentials":["Associate Professor of Medicine\n","Department of Medicine (Nephrology), University of Toronto"],"disclosure":""},{"name":"Bruce A Mueller, PharmD, FCCP, FASN, FNKF","credentials":["Professor and Associate Dean of Academic Affairs\n","University of Michigan College of Pharmacy"],"disclosure":"Grant/Research/Clinical Trial Support: Baxter [CRRT solution]; Merck [Infections (Imipenem/relecactam)]; Cidara Therapeutics [CD101]; MediBeacon [MB102]. Speaker's Bureau: NxStage [SHIFT dialysis]; Baxter [Dialysis]. Employment (spouse/partner): CVS."},{"name":"Jukka Mustonen, MD, PhD","credentials":["Emeritus Professor of Internal Medicine\n","University of Tampere\n","Medical Adviser\n","Tampere University Hospital"],"disclosure":""},{"name":"Tibor Nadasdy, MD","credentials":["Professor of Pathology\n","Director of Renal and Transplant Pathology \n","Ohio State University"],"disclosure":""},{"name":"Samih H Nasr, MD","credentials":["Professor of Laboratory Medicine and Pathology\n","College of Medicine, Mayo Clinic"],"disclosure":""},{"name":"Robert S Negrin, MD","credentials":["Section Editor — Bone Marrow Transplantation\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Immuno-oncology]; Jazz Pharmaceuticals [Veno-occlusive disease (Defibrotide)]; Cell Source [Cellular therapy]; Magenta Pharmaceuticals [Transplantation]. Equity Ownership/Stock Options: Concentrx [Cellular immunotherapy]; Magenta Pharmaceuticals [Transplantation]; Cell Source [Cellular therapy]. Other Financial Interest: American Society of Hematology [Editor in Chief of \"Blood Advances\"]."},{"name":"Peter J Nelson, MD","credentials":["Associate Professor of Medicine\n","University of Washington School of Medicine"],"disclosure":"Consultant/Advisory Boards: Retrophin [Glomerular disease (Sparsentan)]."},{"name":"Gihad E Nesrallah, MD, MSc, FRCPC, FACP","credentials":["Adjunct Professor\n","Western University"],"disclosure":""},{"name":"Patrick Niaudet, MD","credentials":["Section Editor — Pediatric Nephrology\n","Professor of Pediatrics\n","Hôpital Necker-Enfants Malades, Paris, France"],"disclosure":""},{"name":"Thomas Nickolas, MD, MS","credentials":["Associate Professor of Medicine\n","Training Program Directory, Nephrology\n","Columbia University Medical Center, Department of Medicine, Nephrology"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Bone tissue and calcification propensity in end-stage kidney disease (Etelcalcetide)]."},{"name":"Sagar U Nigwekar, MD, MMSc","credentials":["Instructor in Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Hope Pharma [Calciphylaxis (Sodium thiosulfate)]. Other Financial Interest: Sanofi-Aventis [Calciphylaxis (Sevelamer, Doxercalciferol)] (speaking fees)."},{"name":"Marta Novak, MD, PhD","credentials":["Associate Professor of Psychiatry\n","University of Toronto, Canada"],"disclosure":""},{"name":"Gregorio T Obrador, MD, MPH","credentials":["Adjunct Assistant Professor of Medicine \n","Tufts University School of Medicine\n","Dean and Professor of Medicine\n","Universidad Panamericana School of Medicine"],"disclosure":""},{"name":"Iheanyichukwu Ogu, MD","credentials":["Assistant Professor of Medicine, Section of Nephrology\n","Marshall Kidney Care and Hypertension Center\n","Marshall University School of Medicine"],"disclosure":""},{"name":"Ann M O'Hare, MD","credentials":["Associate Professor of Medicine\n","University of Washington School of Medicine"],"disclosure":""},{"name":"Mark D Okusa, MD","credentials":["Professor of Medicine\n","University of Virginia Health System"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [AKI]; John Bower Foundation [AKI]; Pfizer [Acute kidney injury (Recombinant alkaline phosphatase)]. Consultant/Advisory Boards: AM Pharma [AKI]. Patent Holder: B2 pharmaceutical compositions having A2A adenosine receptor agonist activity; Methods and compositions for treating inflammatory response. Equity Ownership/Stock Options: Adenosine Therapeutics [AKI]."},{"name":"Jeffrey W Olin, DO","credentials":["Professor of Medicine (Cardiology)\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"Matthew J Oliver, MD, MHS","credentials":["Associate Professor of Medicine\n","University of Toronto, Canada"],"disclosure":"Equity Ownership/Stock Options: Oliver Medical Management [Vascular access (software measuring dialysis program performance)]."},{"name":"W Charles O'Neill, MD","credentials":["Professor of Medicine\n","Emory University School of Medicine"],"disclosure":""},{"name":"Thomas L Ortel, MD, PhD","credentials":["Professor of Medicine & Pathology\n","Hemostasis & Thrombosis Center, Duke University"],"disclosure":"Grant/Research/Clinical Trial Support: Instrumentation Laboratory [coagulation laboratory testing (coagulation laboratory test instruments and reagents)]; Stago [coagulation laboratory testing (coagulation laboratory test instruments and reagents)]; Siemens [coagulation laboratory testing (coagulation laboratory test instruments and reagents)]."},{"name":"James Owens, MD, PhD","credentials":["Associate Professor of Neurology\n","Adjunct Associate Professor of Pediatrics\n","University of Washington School of Medicine"],"disclosure":""},{"name":"Alison M Pack, MD","credentials":["Associate Professor of Clinical Neurology\n","Columbia University College of Physicians and Surgeons"],"disclosure":""},{"name":"Vernon M Pais, Jr, MD","credentials":["Associate Professor of Surgery/Urology\n","Geisel School of Medicine at Dartmouth"],"disclosure":""},{"name":"Paul M Palevsky, MD","credentials":["Section Editor — Renal Failure\n","Professor of Medicine\n","University of Pittsburgh\n","VA Pittsburgh Healthcare System"],"disclosure":"Grant/Research/Clinical Trial Support: Spectral Medical [Sepsis (Endotoxin assay)]. Consultant/Advisory Boards: Baxter [Dialysis (Hemodialysis equipment, peritoneal dialysis equipment and supplies, continuous renal replacement therapy equipment and solutions)]; Durect [Potential agent for AKI]; HealthSpan Dx [Novel diagnostic test for prediction of AKI]; GE Healthcare [Radiocontrast agents and equipment]."},{"name":"Biff F Palmer, MD","credentials":["Professor of Internal Medicine\n","University of Texas Southwestern Medical Center"],"disclosure":""},{"name":"Alessandra Palmisano, MD, PhD","credentials":["Department of Clinical and Experimental Medicine\n","University of Parma, Italy"],"disclosure":""},{"name":"Shubham Pant, MD","credentials":["Associate Professor\n","Associate Medical Director of The Clinical & Translational Research Center\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Chirag Parikh, MD, PhD","credentials":["Professor of Medicine\n","Yale University School of Medicine"],"disclosure":""},{"name":"Samir M Parikh, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Samir V Parikh, MD","credentials":["Assistant Professor of Clinical Medicine\n","Division of Nephrology\n","The Ohio State University Medical Center"],"disclosure":"Consultant/Advisory Boards: Alexion Pharmaceuticals [Atypical HUS (Eculizumab)]; Aurinia Pharmaceuticals [Lupus nephritis (Voclosporin)]."},{"name":"Rod Passman, MD, MSCE","credentials":["Professor of Medicine\n","Northwestern University Feinberg School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol-Myers [Anticoagulation]; Kardia [Cardiac monitoring]. Speaker's Bureau: Biotronik [Implantable cardiac monitors]; Medtronic [Implantable Cardiac Monitors (Cardiac monitors)]. Consultant/Advisory Boards: Medtronic [Implantable cardiac monitors]."},{"name":"Sassan Pazirandeh, MD","credentials":["Division of Gastroenterology and Hepatology\n","Kaiser Permanente Medical Center"],"disclosure":""},{"name":"York Pei, MD, FRCPC, FACP, FASN","credentials":["Professor of Medicine\n","University Health Network and University of Toronto"],"disclosure":""},{"name":"William F Pendergraft III, MD, PhD","credentials":["Assistant Professor of Medicine, University of North Carolina Kidney Center\n","Visiting Postdoctoral Scholar, Hacohen Group, Broad Institute of Harvard and MIT"],"disclosure":""},{"name":"Mark A Perazella, MD, FACP","credentials":["Professor of Medicine\n","Yale University School of Medicine"],"disclosure":""},{"name":"Leigh Perreault, MD","credentials":["Associate Professor of Medicine\n","University of Colorado Anschutz Medical Campus\n","Associate Professor of Epidemiology\n","Colorado School of Public Health"],"disclosure":"Speaker's Bureau: Novo Nordisk [Obesity (Liraglutide injection)]; Orexigen Therapeutics, Inc [Obesity (naltrexone HCl/bupropion HCl)]. Consultant/Advisory Boards: Novo Nordisk [Obesity (Liraglutide injection)]."},{"name":"Ronald D Perrone, MD","credentials":["Section Editor — Cystic Disease\n","Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [Polycystic kidney disease (Tolvaptan)]; Kadmon [Polycystic kidney disease (Tesevatinib)]; Department of Defense [Polycystic kidney disease (Metformin)]. Consultant/Advisory Boards: Otsuka [Polycystic kidney disease (Tolvaptan)]; Novartis [Polycystic kidney disease]; Misubishi Tanabe [Polycystic kidney disease]; Sanofi-Genzyme [Polycystic kidney disease]."},{"name":"Holly Perry, MD","credentials":["Assistant Professor of Pediatrics\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Andreas Pierratos, MD, FRCPC","credentials":["Professor of Medicine\n","University of Toronto, Canada"],"disclosure":""},{"name":"Nicole A Pilch, PharmD, MSCR, BCPS","credentials":["Clinical Specialist\n","Medical University of South Carolina"],"disclosure":""},{"name":"Duane S Pinto, MD, MPH","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Medtronic [Stents/TAVR (Resolute/Evolut)]; Medicines [ACS (Bivalirudin/Cangrelor)]; Boston Scientific [Coronary stents]; Amarin [Clinical trial event adjudication]. Consultant/Advisory Boards: Abiomed [Circulatory support]; Boston Scientific [Coronary stents]; Terumo [Catheters]."},{"name":"Jeffrey L Platt, MD","credentials":["Professor of Surgery and Microbiology and Immunology\n","University of Michigan"],"disclosure":""},{"name":"Sharon E Plon, MD, PhD","credentials":["Professor, Departments of \n","Pediatrics/Hematology-Oncology\n","Molecular and Human Genetics\n","Human Genome Sequencing Center\n","Baylor College of Medicine"],"disclosure":"Consultant/Advisory Boards: Baylor Genetics Laboratories [genetic testing (hereditary cancer genetic testing)]."},{"name":"Philip J Podrid, MD, FACC","credentials":["Professor of Medicine, Professor of Pharmacology and Experimental Therapeutics \n","Boston University School of Medicine\n","Lecturer, Harvard Medical School"],"disclosure":""},{"name":"Marc A Pohl, MD","credentials":["Ray W. Gifford, Jr., MD Endowed Chair in Hypertension\n","Nephrology and Hypertension\n","Cleveland Clinic"],"disclosure":""},{"name":"Didier Portilla, MD","credentials":["Professor of Medicine\n","University of Virginia"],"disclosure":""},{"name":"Raoul Poupon, MD","credentials":["Professor of Hepatology and Gastroenterology\n","University Pierre et Marie Curie\n","UPMC, Sorbonne University, Paris, France"],"disclosure":"Consultant/Advisory Boards: Intercept Pharma."},{"name":"Manuel Praga, MD, PhD","credentials":["Professor of Medicine\n","Complutense University, Madrid"],"disclosure":"Speaker's Bureau: Alexion [Hemolytic uremic syndrome (Eculizumab)]; Otsuka [Polycystic kidney disease (Tolvaptan)]; Fresenius [Hemodialysis]. Consultant/Advisory Boards: Alexion [Hemolytic uremic syndrome (Eculizumab)]; Otsuka [Polycystic kidney disease (Tolvaptan)]; Fresenius [Hemodialysis]."},{"name":"Glenn M Preminger, MD","credentials":["Section Editor — Renal Ureteral Stones\n","Professor of Urologic Surgery\n","Duke University Medical Center\n","Director of Education\n","Endourological Society"],"disclosure":"Consultant/Advisory Boards: Retrophin [Cystine stones (Tiopronin)]; Boston Scientific [Surgical stone management (Endourology equipment)]."},{"name":"Ching-Hon Pui, MD","credentials":["Chair of the Department of Oncology\n","Fahad Al-Rashid Chair of Leukemia Research\n","St. Jude's Children's Hospital\n","American Cancer Society Professor \n","Professor of Pediatrics\n","University of Tennessee Health Science Center"],"disclosure":"Consultant/Advisory Boards: Adaptive Biotechnologies [Deep sequencing for minimal residual disease detection]."},{"name":"Charles D Pusey, MD","credentials":["Professor of Medicine\n","Imperial College, London"],"disclosure":""},{"name":"L Darryl Quarles, MD","credentials":["Section Editor — Renal Osteodystrophy\n","Director, Division of Nephrology\n","Associate Dean for Research\n","The University of Tennessee Health Science Center"],"disclosure":"Speaker's Bureau: Amgen [Calcimimetic (Cinacalcet)]."},{"name":"Wajeh Y Qunibi, MD","credentials":["Professor of Medicine\n","University of Texas Health Sciences Center"],"disclosure":""},{"name":"Jai Radhakrishnan, MD, MS","credentials":["Professor of Medicine\n","Columbia University Medical Center"],"disclosure":""},{"name":"Hershel Raff, PhD","credentials":["Professor of Medicine\n","Medical College of Wisconsin"],"disclosure":"Consultant/Advisory Boards: Millendo, Corcept, Cerium [laboratory testing for HPA axis disorders]."},{"name":"Frederic F Rahbari-Oskoui, MD, MSCR","credentials":["Associate Professor of Medicine\n","Emory University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [ADPKD (Tolvaptan)]; Kadmon [ADPKD (Tesevatinib)]. Consultant/Advisory Boards: Kadmon [ADPKD (Tesevatinib)]."},{"name":"S Vincent Rajkumar, MD","credentials":["Edward W. and Betty Knight Scripps Professor of Medicine\n","Mayo Clinic"],"disclosure":""},{"name":"Emilio Ramos, MD, FACP","credentials":["Clinical Professor of Medicine\n","University of Buffalo, School of Medicine\n","Buffalo, NY"],"disclosure":""},{"name":"Stephanie Randle, MD, MS","credentials":["Clinical Assistant Professor of Pediatric Neurology and Epilepsy\n","University of Washington and Seattle Children's Hospital"],"disclosure":""},{"name":"Jochen Reiser, MD, PhD","credentials":["The Ralph C Brown MD Professor\n","Chairman of Medicine\n","Rush University"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [nephrology (Kidney Disease)]. Consultant/Advisory Boards: Astellas [nephrology (lecture about mechanisms of Kidney disease)]; Questcor [nephrology (lecture about mechanisms of kidney disease)]; Mass General Hospital [nephrology (consultant to research laboratory design and programs in nephrology)]. Patent Holder: TRISAQ [Co-founder/stock holder (Development of bio device for removal of circulating factor in FSGS)]. Equity Ownership/Stock Options: [Co-founder/stock holder (Development of bio device for removal of circulating factor in FSGS)]."},{"name":"Sean H Rhyee, MD, MPH","credentials":["Assistant Professor of Emergency Medicine, Division of Medical Toxicology\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Jerome P Richie, MD, FACS","credentials":["Section Editor — Cancer of the Urethra, Penis, and Ureter; Urologic Surgery; Prostate Cancer\n","Elliott Carr Cutler Professor of Surgery\n","Harvard Medical School"],"disclosure":""},{"name":"Gianfranco Rizzato, MD","credentials":["Primario Emerito Internal Medicine\n","Niguarda Hospital (Piazza Ospedale Maggiore)"],"disclosure":""},{"name":"Darren M Roberts, MBBS, PhD, FRACP","credentials":["Clinical Toxicologist, Royal Prince Alfred Hospital\n","Nephrologist, Canberra Hospital\n","Associate Professor, Australian National University"],"disclosure":""},{"name":"Dario Roccatello, MD","credentials":["Professor of Nephrology and Clinical Pathology\n","University of Turin Medical School"],"disclosure":"Consultant/Advisory Boards: Genzyme [Eliglustat (Gaucher Disease)]."},{"name":"Michael Rocco, MD, MS","credentials":["Professor of Medicine\n","Wake Forest University School of Medicine"],"disclosure":""},{"name":"Richard J Rodeheffer, MD","credentials":["Professor of Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"Rebecca Rojas, MD","credentials":["Associate Professor of Internal Medicine\n","Medical Director, Kidney Pre-transplantation, Department of Nephrology\n","University of Texas Southwestern Medical Center"],"disclosure":""},{"name":"Pierre Ronco, MD, PhD","credentials":["Professor of Renal Medicine\n","Pierre et Marie Curie University, France"],"disclosure":"Grant/Research/Clinical Trial Support: AMGEN [Rare genetic diseases of the kidney]; Alexion [Membranous Nephropathy (Eculizumab)]."},{"name":"Guy Rordorf, MD","credentials":["Associate Professor of Neurology\n","Harvard Medical School"],"disclosure":""},{"name":"Clifford J Rosen, MD","credentials":["Section Editor — Bone Disease\n","Professor of Nutrition\n","University of Maine\n","Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Harold N Rosen, MD","credentials":["Associate Professor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Mark Rosenberg, MD","credentials":["Professor of Medicine\n","University of Minnesota Medical School"],"disclosure":""},{"name":"Mitchell H Rosner, MD","credentials":["Professor of Medicine\n","University of Virginia Health System"],"disclosure":""},{"name":"Douglas S Ross, MD","credentials":["Section Editor — Thyroid Disease\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board: Medullary Thyroid Cancer Registry Consortium [Thyroid cancer]; Shire [Hypoparathyroidism (Parathyroid hormone for injection)]; Spectrix Therapeutics, LLC [Hypothyroidism (Thyroid hormone)]. Other Financial Interests: Abbott India (honorarium) [Hyperthyroidism (carbimazole, levothyroxine)]; Quest Diagnostics (honorarium) [Hyperthyroidism]."},{"name":"Ana P Rossi, MD, MPH","credentials":["Transplant Nephrologist, Maine Transplant Program\n","Maine Medical Center"],"disclosure":""},{"name":"Lionel Rostaing, MD, PhD","credentials":["Department of Nephrology, Hemodialysis, Apheresis, and Renal Transplantation\n","Grenoble Alpes University Hospital, France"],"disclosure":"Grant/Research Support: Hemat; Teriemo; Chiesi; Novartis; Astellas; Neovii."},{"name":"Brad H Rovin, MD","credentials":["Section Editor — Glomerular Diseases \n","Professor of Medicine and Pathology\n","The Ohio State University College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Glomerular Diseases/Molecular Interrogation of Kidney Biopsies, Precision Medicine/Biomarkers]. Consultant/Advisory Boards: Alexion [Lupus Nephritis (Eucluzimab)]; Aurinia [Lupus Nephritis, FSGS (Voclosporin)]; Biogen Idec [Lupus Nephritis (Anti-TWEAK)];  Biomarin [Hereditary Disorders of Metabolic Disorders (Pegvaliase)]; Bristol Myers Squibb [FSGS, MCD (Abatacept)]; Chemocentryx [Lupus Nephritis, ANCA Vasculitis, C3 Glomerulopathy (Avacopan)]; EMD Serono [IgA Nephropathy (Atacicept)]; Frazier Life Sciences [Lupus Nephritis]; Genentech [Lupus Nephritis, ANCA Vasculitis (Rituximab, Obinutuzumab)]; Lupus Foundation of America [Lupus Nephritis]; Mallinkrodt [Lupus Nephritis, FSGS (ACTHAR Gel)]; Medimmune [Lupus Nephritis (Anti-interferon)]; Novartis [IgA Nephropathy (Factor B Inhibitor)]; Pharmalink [IgA Nephropathy]; Retrophin [IgA Nephropathy (Sparsenten)]; Rigel [IgA Nephropathy (Fostamatinib])."},{"name":"Michael R Rudnick, MD","credentials":["Associate Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Andrew D Rule, MD, MSc","credentials":["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Bruce A Runyon, MD","credentials":["Section Editor — Cirrhosis and Its Complications\n","Special Hepatology Consultant to the Indian Health Service \n","Northern Navajo Medical Center, Shiprock, New Mexico"],"disclosure":""},{"name":"Kenneth G Saag, MD, MSc","credentials":["Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Osteoporosis]; Ironwood/AstraZeneca [Gout]; Merck [Osteoporosis]; Takeda [Gout]; Horizon [Gout]; SOBI [Gout]. Consultant/Advisory Boards: Ironwood/AstraZeneca [Gout, rheumatoid arthritis]; Takeda [Gout]; Amgen [Osteoporosis, rheumatoid arthritis]; Merck [Osteoporosis, rheumatoid arthritis]; Abbott [Rheumatoid arthritis]; Bristol-Myers Squibb [Rheumatoid arthritis]; Pfizer [Rheumatoid arthritis]; Roche-Genentech [Rheumatoid arthritis]; Bayer [Rheumatoid arthritis]; Horizon [Gout]; Radius [Osteoporosis]; SOBI [Gout]; Lilly [Osteoporosis]."},{"name":"A Mazin Safar, MD","credentials":["Associate Professor of Medicine\n","University of Arkansas for Medical Sciences"],"disclosure":""},{"name":"Takao Saito, MD, PhD","credentials":["Professor Emeritus, Fukuoka University\n","Director, Sanko Clinic\n","Specified Medical Corporation Sanko Group"],"disclosure":"Speaker's Bureau: Daiichi-Sankyo [Dyslipidemia (Pravastatin)]; AstraZeneca [Dyslipidemia (Rosuvastatin)]; Kowa [Dyslipidemia (Pitavastatin)]."},{"name":"David J Salant, MD","credentials":["Professor of Medicine\n","Boston University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer CTI [Kidney disease]. Consultant/Advisory Boards: Visterra [Glomerular disease]; Genzyme/Sanofi [Membranous nephropathy (Agalsidase-beta)]; Pfizer [Data monitoring board for anti-inflammatory drug trial]; Chugai [models of kidney fibrosis]. Patent Holder: Boston Medical Center [Diagnostics for membranous nephropathy]."},{"name":"Neil S Sanghani, MD","credentials":["Assistant Professor of Medicine\n","Vanderbilt University Medical Center"],"disclosure":""},{"name":"Carlos AQ Santos, MD, MPHS","credentials":["Associate Professor of Medicine\n","Rush University Medical Center"],"disclosure":""},{"name":"Mark Sarnak, MD","credentials":["Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Akebia steering committee [Hypoxia inducible factor therapy]."},{"name":"Deirdre Sawinski, MD, FAST","credentials":["Assistant Professor of Medicine\n","Assistant Medical Director, Kidney Pancreas Transplantation\n","Renal Electrolyte and Hypertension Division\n","Hospital of the University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Merck [HW treatment (elbasvir-grazoprevir)]."},{"name":"Steven J Scheinman, MD","credentials":["President and Dean, Professor of Medicine\n","Geisinger Commonwealth School of Medicine"],"disclosure":""},{"name":"Jane O Schell, MD","credentials":["Assistant Professor of Medicine\n","University of Pittsburgh School of Medicine"],"disclosure":""},{"name":"Raphael Schiffmann, MD, MHSc","credentials":["Director of the Institute of Metabolic Disease\n","Adjunct Professor of Biomedical Studies\n","Baylor University Medical Center"],"disclosure":"Grant/Research Support: Shire [Fabry disease (Agalsidase alfa); Protalix [Fabry disease (PRX-102); Amicus [Fabry disease (Migalastat)]; Sanofi Genzyme [Gaucher disease type 3 (Venglustat)]. Consultant/Advisory Boards: Protalix [Fabry disease (PRX-102)]; Amicus Therapeutics [Fabry disease (Migalastat)]."},{"name":"Rebecca J Schmidt, DO, FACP","credentials":["Professor of Medicine\n","West Virginia University School of Medicine"],"disclosure":""},{"name":"Peter H Schur, MD","credentials":["Editor-in-Chief — Rheumatology\n","Section Editor — Basic Science\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Marvin I Schwarz, MD","credentials":["Professor of Medicine\n","University of Colorado Denver, School of Medicine"],"disclosure":""},{"name":"Francesco Scolari, MD","credentials":["Professor of Nephrology\n","University of Brescia"],"disclosure":""},{"name":"Sanjeev Sethi, MD, PhD","credentials":["Professor of Laboratory Medicine and Pathology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Mehmet S Sever, MD","credentials":["Professor of Medicine\n","Istanbul School of Medicine"],"disclosure":"Consultant/Advisory Boards: Fresenius Medical Care Turkey [Chronic hemodialysis patients treatment]. Other Financial Interest: Amgen [Chronic kidney disease-mineral bone disease]."},{"name":"Daniel J Sexton, MD","credentials":["Editor-in-Chief — Infectious Diseases\n","Section Editor — Bacterial Infections\n","Professor of Medicine\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Centers for Disease Control and Prevention; National Institutes of Health [Healthcare epidemiology]. Consultant/Advisory Boards: Sterilis [Medical waste disposal]; Magnolia Medical Technologies [Medical diagnostics]; National Football League [Infection prevention]; Johnson & Johnson [Mesh-related infections]. Equity Ownership/Stock Options: Magnolia Medical Technologies [Medical diagnostics (Blood culture techniques)]. Other Financial Interest: Johnson & Johnson [Mesh-related infections]."},{"name":"Elizabeth Shane, MD","credentials":["Professor of Medicine\n","Columbia University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Osteoporosis (denosumab)]. Consultant/Advisory Boards: Amgen [Osteoporosis (denosumab)]."},{"name":"Melissa L Shannon, MD","credentials":["Staff Physician\n","Catholic Health Initiatives\n","St Vincent Health System"],"disclosure":""},{"name":"Charles L Shapiro, MD","credentials":["Professor of Medicine\n","Director of Translational Breast Cancer Research\n","Director of Cancer Survivorship, Tisch Cancer Institute"],"disclosure":""},{"name":"Ron Shapiro, MD","credentials":["Professor of Surgery\n","Surgical Director, Kidney/Pancreas Transplant Program\n","Mount Sinai Hospital - Recanati Miller Transplantation Institute"],"disclosure":""},{"name":"Alice M Sheridan, MD","credentials":["Deputy Editor — Nephrology\n","Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Richard A Sherman, MD","credentials":["Professor of Medicine\n","Rutgers - Robert Wood Johnson Medical School"],"disclosure":"Consultant/Advisory Boards: Merck [Hepatitis C (Elbasvir and grazoprevir)]."},{"name":"Baha M Sibai, MD","credentials":["Professor, Maternal-Fetal Medicine Division\n","Department of Obstetrics, Gynecology and Reproductive Sciences\n","The University of Texas Medical School at Houston"],"disclosure":""},{"name":"Edward D Siew, MD, MSCI","credentials":["Assistant Professor of Medicine\n","Division of Nephrology and Hypertension, Vanderbilt Center for Kidney Disease (VCKD)\n","Vanderbilt University Medical Center"],"disclosure":""},{"name":"Shonni J Silverberg, MD","credentials":["Professor of Medicine\n","Columbia University College of Physicians and Surgeons"],"disclosure":""},{"name":"Albert L Siu, MD, MSPH","credentials":["Professor\n","Department of Geriatrics and Pallative Medicine\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"Marco L A Sivilotti, MD, MSc, FRCPC, FACMT, FAACT","credentials":["Professor of Emergency Medicine and of Biomedical & Molecular Sciences\n","Queen's University, Kingston Canada"],"disclosure":""},{"name":"Roderick Skinner, PhD, MBChB, FRCPCH","credentials":["Consultant in Paediatric and Adolescent Oncology/Bone Marrow Transplantation\n","Honorary Professor of Childhood Cancer\n","Great North Children's Hospital\n","Northern Institute of Cancer Research, Newcastle University"],"disclosure":""},{"name":"Timothy W Smith, MD, PhD","credentials":["Associate Professor of Medicine\n","Washington University School of Medicine"],"disclosure":""},{"name":"Peter J Snyder, MD","credentials":["Editor-in-Chief — Endocrinology\n","Section Editor — Pituitary Disease; Male Reproductive Endocrinology\n","Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Hypogonadism (Testosterone gel)]; Novo Nordisk [Growth hormone (Somatropin)]; Novartis [Cushing's (LCI699)]; Cortendo [Cushing's]. Consultant/Advisory Boards: AbbVie [Hypogonadism (Testosterone gel)]; Novartis [Cushing's (LCI699)]; Pfizer [Acromegaly (Pegvisomant)]; Watson [Testosterone (Testosterone gel)]."},{"name":"Michael J Somers, MD","credentials":["Associate Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Ramesh Soundararajan, MD, FACP","credentials":["Clinical Assistant Professor of Internal Medicine\n","Midwestern University College of Medicine"],"disclosure":""},{"name":"Theodore I Steinman, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Kadmon [Tyrosine kinase inhibitor (Tesevitanib)]; Fibrogen [Hypoxia inducible factor (Roxadustat)]. Consultant/Advisory Boards: Genzyme [Polycystic kidney disease]."},{"name":"Richard H Sterns, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Professor Emeritus\n","University of Rochester School of Medicine and Dentistry"],"disclosure":""},{"name":"Robert J Stratta, MD","credentials":["Professor of Surgery, Director of Transplantation\n","Wake Forest School of Medicine"],"disclosure":""},{"name":"Jason R Stubbs, MD","credentials":["Associate Professor of Medicine\n","Division of Nephrology & Hypertension\n","University of Kansas Medical Center"],"disclosure":""},{"name":"José Such, MD, PhD","credentials":["Digestive Disease Institute, Cleveland Clinic Abu Dhabi, UAE\n","Clinical Professor, Lerner School of Medicine. Case Western Reserve University, OH, US"],"disclosure":""},{"name":"Harold Szerlip, MD, FACP, FCCP, FASN, FNKF","credentials":["Director, Nephrology Division, Baylor University Medical Center, Dallas\n","Program Director, Nephrology Training Program, Baylor University Medical Center\n","Clinical Professor of Medicine, Texas A&M College of Medicine\n","Adjunct Professor of Medicine, Texas College of Osteopathic Medicine"],"disclosure":""},{"name":"Matthew D Sztajnkrycer, MD, PhD","credentials":["Associate Professor of Emergency Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"James Tattersall, MD, MRCP","credentials":["Specialty Doctor in Renal Medicine\n","Leeds Teaching Hospitals Trust"],"disclosure":""},{"name":"Eric N Taylor, MD, MSc","credentials":["Associate Professor of Medicine\n","Tufts University School of Medicine\n","Division of Nephrology and Transplantation\n","Maine Medical Center"],"disclosure":"Consultant/Advisory Boards: Allena Pharmaceuticals [Kidney stones and enteric hyperoxaluria (oxalate-degrading enzyme)]."},{"name":"Pablo Tebas, MD","credentials":["Professor of Medicine\n","University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Merck [HIV treatment (Raltegravir)], Glaxo [Adjudication Committee (VZV vaccine)]."},{"name":"Stephen Textor, MD","credentials":["Professor of Medicine\n","Division of Nephrology and Hypertension\n","Mayo Clinic College of Medicine\n","Rochester, Minnesota"],"disclosure":"Grant/Research/Clinical Trial Support: Stealth Biopharmaceuticals [Mitochondrial protection (Bendavia)]."},{"name":"Ravi I Thadhani, MD, MPH","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"George Thomas, MD, MPH, FACP, FASN","credentials":["Director, Center for Blood Pressure Disorders, Cleveland Clinic \n","Assistant Professor, Cleveland Clinic Lerner College of Medicine"],"disclosure":""},{"name":"Garry S Tobin, MD","credentials":["Professor of Medicine\n","Washington University School of Medicine"],"disclosure":"Speaker's Bureau: Novo Nordisk [Diabetes (Insulin degludec, insulin detemir, NPH, insulin, liraglutide)]; MannKind [Diabetes (Inhaled insulin)]."},{"name":"Ashita J Tolwani, MD","credentials":["Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: Baxter; NxStage [CRRT (CRRT training)]. Speaker's Bureau: Baxter [CRRT (CRRT devices)]. Consultant/Advisory Boards: Baxter [CRRT (CRRT devices)]. Patent Holder: Baxter [CRRT (0.5 percent citrate anticoagulation for CRRT)]."},{"name":"Marcello Tonelli, MD, SM, FRCPC","credentials":["Associate Vice President (Health Research), University of Calgary\n","Senior Associate Dean (Clinical Research), Cumming School of Medicine\n","Professor of Medicine, University of Calgary"],"disclosure":""},{"name":"Vicente E Torres, MD","credentials":["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support [Otsuka (ADPKD)]."},{"name":"Raymond R Townsend, MD","credentials":["Professor of Medicine\n","Perelman School of Medicine\n","University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: NIH Grants (chronic kidney disease progression and CKD comorbidities). Consultant/Advisory Boards: Medtronic [Hypertension (Renal denervation catheter)]. Other Financial Interest: Travel support from NKF and ASN (hypertension, CKD)."},{"name":"Stephen J Traub, MD","credentials":["Section Editor — Toxicology\n","Associate Professor of Emergency Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"Augusto Vaglio, MD, PhD","credentials":["Nephrology\n","University Hospital, Parma, Italy"],"disclosure":""},{"name":"Raymond Vanholder, MD, PhD","credentials":["Professor Emeritus of Medicine\n","University Hospital, Ghent, Belgium"],"disclosure":"Consultant/Advisory Boards: Debiotech [Hemodialyzers]."},{"name":"John Varga, MD","credentials":["John and Nancy Hughes Professor of Medicine\n","Northwestern University Feinberg School of Medicine"],"disclosure":""},{"name":"Joseph Varon, MD, FACP, FCCP, FCCM, FRSM","credentials":["Professor of Acute and Continuing Care, The University of Texas Health Science Center at Houston\n","Clinical Professor of Medicine, The University of Texas Medical Branch"],"disclosure":""},{"name":"Larissa I Velez, MD","credentials":["Professor of Emergency Medicine\n","University of Texas Southwestern Medical Center"],"disclosure":""},{"name":"John Vella, MD, FACP, FRCP, FASN, FAST","credentials":["Associate Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas; Bristol Myers Squibb [Transplantation (CMV vaccine, belatacept)]."},{"name":"Vijaya Venkataraman, MD","credentials":["Consultant Nephrologist\n","Kidney Specialists Inc. Columbus, OH"],"disclosure":""},{"name":"Sebastien Viatte, MD, PhD","credentials":["Lecturer in Genetics\n","Arthritis Research UK Centre for Genetics and Genomics\n","The University of Manchester, UK"],"disclosure":""},{"name":"R Kasi Visweswaran, MD, DM, FRCP (Edin)","credentials":["Consultant in Nephrology\n","Ananthapuri Hospital and Research Institute"],"disclosure":""},{"name":"Demetrios V Vlahakos, MD","credentials":["Professor of Medicine and Nephrology, Director, Renal Unit \n","Attikon University Hospital \n","Athens University School of Medicine\n","National and Kapodistrian University of Athens"],"disclosure":""},{"name":"Ron Wald, MDCM, MPH, FRCPC","credentials":["Associate Professor, Department of Medicine \n","University of Toronto"],"disclosure":""},{"name":"David Richard Walega, MD","credentials":["Associate Professor\n","Northwestern University Feinberg School of Medicine"],"disclosure":""},{"name":"Richard A Ward, PhD","credentials":["Professor of Medicine\n","University of Louisville"],"disclosure":"Consultant/Advisory Boards: Baxter Healthcare [Hemodialysis devices]."},{"name":"Alan Wasserstein, MD","credentials":["Associate Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Terry Watnick, MD","credentials":["Associate Professor of Medicine\n","University of Maryland School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [Polycystic kidney disease (Tolvaptan)]. Consultant/Advisory Board: PKD Foundation [Polycystic kidney disease]. Patent Holder: Athena Diagnostics [Polycystic kidney disease (PKD gene testing)]. Patent Holder (spouse): Athena Diagnostics [Polycystic kidney disease (PKD gene testing)]."},{"name":"Virginia M Weaver, MD, MPH","credentials":["Associate Professor of Environmental Health Sciences and Medicine\n","Associate Faculty Member, Welch Center for Prevention, Epidemiology and Clinical Research \n","Johns Hopkins Medical Institutions"],"disclosure":""},{"name":"Liza M Weavind, MBBCh, FCCM, MMHC","credentials":["Professor of Anesthesiology and Surgery\n","Vanderbilt University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Medtronic [Capnostream]."},{"name":"Kathryn W Weibrecht, MD","credentials":["Emergency Medicine Physician\n","Morton Hospital"],"disclosure":""},{"name":"Steven E Weinberger, MD","credentials":["Adjunct Professor of Medicine\n","University of Pennsylvania School of Medicine\n","Executive Vice President and CEO Emeritus\n","American College of Physicians"],"disclosure":""},{"name":"Amy C Weintrob, MD","credentials":["Associate Professor of Medicine\n","The George Washington University and Veterans Affairs Medical Center"],"disclosure":""},{"name":"Annika O Wernerson, MD, PhD","credentials":["Professor and Senior Consultant in Pathology\n","Karolinska Institute, Sweden"],"disclosure":""},{"name":"Jack FM Wetzels, MD, PhD","credentials":["Professor of Nephrology\n","Radboud University Medical Center, Nijmegen, The Netherlands"],"disclosure":""},{"name":"William L Whittier, MD","credentials":["Associate Professor of Medicine\n","Rush University Medical Center"],"disclosure":""},{"name":"Michael Wiederkehr, MD","credentials":["Associate Professor, Department of Internal Medicine\n","Texas A&M Health Science Center College of Medicine, Dallas"],"disclosure":""},{"name":"James F Winchester, MD","credentials":["Professor of Medicine\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"Karen Woo, MD","credentials":["Associate Professor\n","UCLA Division of Vascular Surgery"],"disclosure":""},{"name":"Christina M Wyatt, MD","credentials":["Associate Professor\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"Sri G Yarlagadda, MD","credentials":["Associate Professor\n","University of Kansas Medical Center"],"disclosure":""},{"name":"Melissa Y Yeung, MD, FRCPC","credentials":["Instructor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Linwah Yip, MD","credentials":["Associate Professor of Surgery\n","University of Pittsburgh School of Medicine"],"disclosure":""},{"name":"William F Young, Jr, MD, MSc","credentials":["Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Consultant/Advisory Boards: Nihon Medi-Physics Co, Ltd [Primary aldosteronism (Novel PET-based adrenal imaging)]."},{"name":"Alan S L Yu, MB, BChir","credentials":["Harry Statland and Solon Summerfield Professor of Medicine\n","University of Kansas Medical Center"],"disclosure":""},{"name":"Elaine W Yu, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Mark L Zeidel, MD","credentials":["Hermann L. Blumgart Professor of Medicine\n","Harvard Medical School Physician-in-Chief and Chair\n","Department of Medicine Beth Israel Deaconess Medical Center"],"disclosure":""},{"name":"Stéphane Zuily, MD, MPH, PhD","credentials":["Associate Professor of Medicine, Nancy School of Medicine of Lorraine University\n","Attending Physician, Vascular Medicine Division, Nancy Academic Hospital"],"disclosure":""}]},{"name":"Peer Reviewers","contributors":[{"name":"Nada Alachkar, MD","credentials":["Associate Professor of Medicine, Division of Nephrology\n","The Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Michael Allon, MD","credentials":["Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":"Consultant/Advisory Boards: Cormedix [Dialysis catheter infections (nonantibiotic antimicrobial solution)]."},{"name":"Anatole Besarab, MD","credentials":["Professor of Medicine\n","West Virginia University School of Medicine"],"disclosure":"Consultant/Advisory Boards: VascAlert [Vascular access for hemodialysis (Surveillance technique)]. Employment: Fibrogen [Anemia of CKD (Roxadustat)] - No relevant conflict on topic."},{"name":"Daniel G Bichet, MD","credentials":["Professor of Medicine\n","Universite de Montreal"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry (Migalastat)], Shire [Fabry (Replagal)], Sanofi Genzyme [Fabry (Fabrazyme)]. Speaker's Bureau: Otsuka Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry (Migalastat)], Sanofi Genzyme [Fabry (Fabrazyme)]. Consultant/Advisory Boards: Otsuka Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry (Migalastat)], Sanofi Genzyme [Fabry (Fabrazyme)]."},{"name":"Roy D Bloom, MD","credentials":["Professor of Medicine\n","University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Veloxis Pharmaceuticals [Immunosuppression (Tacrolimus)]; Care DX [Diagnostics (DNA blood test)]. Consultant/Advisory Boards: Abbvie [Hepatitis C (Ombitasvir, paritaprevir, ritonavir, plus dasabuvir)]; Merck [Hepatitis C (Elbasvir and grazoprevir)]; Care Dx [Diagnostics (DNA blood test)]."},{"name":"John M Burkart, MD","credentials":["Section Editor — Dialysis\n","Professor of Medicine/Nephrology\n","Wake Forest University Medical Center"],"disclosure":"Employment: Health Systems Management."},{"name":"Daniel C Cattran, MD","credentials":["Professor of Medicine\n","University of Toronto, Canada"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Membranous nephropathy, FSGS (Rituximab)]; Chemocentryx [FSGS]. Consultant/Advisory Boards: Mallinckrodt [Membranous nephropathy; focal and segmental glomerulosclerosis (ACTH long-acting gel)]; Omerus [IgA]; Chemocentryx [Vasculitis (C3G), FSGS]."},{"name":"Anil Chandraker, MD, FASN, FRCP","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [Antibody-mediated rejection (Eculizumab)]. Consultant/Advisory Boards: T2 Biosystems; Dompé; Veloxis [Immunosuppression (Tacrolimus)]."},{"name":"Marc E De Broe, MD, PhD","credentials":["Emeritus Professor of Medicine\n","University of Antwerp, Belgium"],"disclosure":""},{"name":"Bradley M Denker, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Joel D Glickman, MD","credentials":["Professor of Clinical Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"David S Goldfarb, MD, FACP, FASN","credentials":["Professor of Medicine and Physiology\n","New York University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Allena [Nephrolithiasis (Allena 177)]; Retrophin (Cystinuria (Tiopronin)]. Patent Holder: Ravine Group [Nephrolithiasis, cystinuria]."},{"name":"David JA Goldsmith, MA, FRCP","credentials":["Visiting Professor\n","St. George's Hospital University Medical School\n","GI Popescu School of Pharmacy and Medicine"],"disclosure":"Speaker's Bureau: Amgen [CKD-MBD (Cinacalcet)]; Vifor [CKD-MBD (Iron sucrose hydroxyoxide)]; Abbvie [CKD-MBD (Paricalcitol)]; Sanofi [CKD-MBD (Sevelamer)]. Consultant/Advisory Board: Amgen [CKD-MBD (Cinacalcet)]; Vifor [CKD-MBD (Iron sucrose hydroxyoxide)]; Abbvie [CKD-MBD (Paricalcitol)]; Sanofi [CKD-MBD (Sevelamer)]."},{"name":"L Lee Hamm, MD","credentials":["Professor of Medicine\n","Tulane University School of Medicine"],"disclosure":""},{"name":"Karen Hardinger, PharmD, BCPS","credentials":["Clinical Professor\n","University of Missouri-Kansas City"],"disclosure":""},{"name":"Jean L Holley, MD, FACP","credentials":["Clinical Professor of Medicine\n","University of Illinois, Urbana-Champaign"],"disclosure":""},{"name":"Keith Hruska, MD","credentials":["Ira M Lang Professor of Medicine\n","Washington University Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene [Renal fibrosis, CKD-MBD (Sotatercept)]. Consultant/Advisory Boards: Celgene; Vifor [CKD-MBD (Sucroferric oxyhydroxide)]; Medikine."},{"name":"Chi-yuan Hsu, MD, MSc","credentials":["Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Ramesh Khanna, MD, FACP","credentials":["Karl D Nolph, MD Chair in Nephrology, Professor of Medicine\n","Vice Chair, Department of Medicine\n","Director, Division of Nephrology\n","University of Missouri-Columbia"],"disclosure":""},{"name":"Christina L Klein, MD","credentials":["Transplant Nephrologist\n","Piedmont Transplant Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [CMV (CMV vaccine)]; Chimerix [CMV (Brincidofovir)]. Speaker's Bureau: Alexion [Atypical HUS (Eculizumab)]. Consultant/Advisory Boards: Alexion [Atypical HUS (Eculizumab)]."},{"name":"Edgar V Lerma, MD, FACP, FASN, FAHA","credentials":["SGIM Peer Reviewer\n","Clinical Professor of Medicine\n","University of Illinois at Chicago College of Medicine"],"disclosure":""},{"name":"Robert G Luke, MD","credentials":["Taylor Professor of Medicine\n","University of Cincinnati Medical Center"],"disclosure":""},{"name":"Orson Moe, MD","credentials":["Professor of Medicine\n","UT Southwestern Medical Center at Dallas"],"disclosure":"Consultant/Advisory Boards: Allena Pharmaceuticals [Hyperoxaluria]; Ardelyx [Hyperphosphatemia]."},{"name":"David B Mount, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Ardea [Urate transport (Lesinurad)]. Consultant/Advisory Boards: ZS Pharma [Potassium (ZS9)]; Relypsa [Potassium (Patiromer)]."},{"name":"Mark D Okusa, MD","credentials":["Professor of Medicine\n","University of Virginia Health System"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [AKI]; John Bower Foundation [AKI]; Pfizer [Acute kidney injury (Recombinant alkaline phosphatase)]. Consultant/Advisory Boards: AM Pharma [AKI]. Patent Holder: B2 pharmaceutical compositions having A2A adenosine receptor agonist activity; Methods and compositions for treating inflammatory response. Equity Ownership/Stock Options: Adenosine Therapeutics [AKI]."},{"name":"Mark Rosenberg, MD","credentials":["Professor of Medicine\n","University of Minnesota Medical School"],"disclosure":""},{"name":"John Vella, MD, FACP, FRCP, FASN, FAST","credentials":["Associate Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas; Bristol Myers Squibb [Transplantation (CMV vaccine, belatacept)]."},{"name":"Anitha Vijayan, MD","credentials":["Associate Professor of Medicine\n","Washington University St Louis"],"disclosure":"Speaker's Bureau: NxSTage [CRRT, AKI (Hemodialysis machine)]; Sanofi [Tumor lysis, AKI (Rasburicase)]."},{"name":"Sushrut S Waikar, MD, MPH","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Genzyme [AKI]; Merck [AKI]; Otsuka [Hyponatremia]; Pfizer [AKI]; Satellite [ESRD]; Biogen [Biomarkers]; Allena [CKD]. Consultant/Advisory Boards: Abbvie [CKD (Endothelin antagonist)]; CVS Caremark [CKD]; Takeda [Hyponatremia (Tolvaptan, febuxostat]; Harvard Clinical Research Institute [CKD (Canagliflozin)]; GSK [HIF stabilizers, biomarkers]; Merck [Biomarkers]; Cerus [design of AKI trials]. Other Financial Interest: GE Healthcare [ESRD (Gadodiamide)]; Fresenius [ESRD (Dialysis concentrate)]; Pfizer [atorvastatin and diabetes]; Mercury exposure litigation."},{"name":"Elaine Worcester, MD","credentials":["Professor of Medicine\n","University of Chicago"],"disclosure":"Consultant/Advisory Boards: Allena [Product to increase gut metabolism of oxalate]; OxThera [Product to increase gut metabolism of oxalate]."},{"name":"Melissa Y Yeung, MD, FRCPC","credentials":["Instructor in Medicine\n","Harvard Medical School"],"disclosure":""}]}]}